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ABSTRACT
Chlorinated anilines have been used as important chemical intermediates in the production of a
wide variety of pharmaceutical, industrial, and agricultural products. Exposure to chloroanilines
can arise in both occupational and environmental settings and can lead to toxicity to multiple
organs, including the kidney. Previous studies have established that of the mono- and
dichlorinated anilines, 3,5-dichloroaniline (3,5-DCA) possesses the most nephrotoxic potential
both in vitro and in vivo. However, little is known concerning the role of renal metabolism in
nephrotoxicity. The studies presented in the following dissertation are the first to explore the
toxicity, metabolism, and bioactivation of 3,5-DCA in isolated renal cortical cells (IRCC)
obtained from male Fischer 344 rats, as well as to explore the nephrotoxic potential of putative
3,5-DCA metabolites. Results show that in IRCC, 3,5-DCA induced cytotoxicity in a
concentration- and time-dependent manner. Further studies suggested that 3,5-DCA induced
nephrotoxicity is due, at least in part, to bioactivation of 3,5-DCA to toxic metabolites via
multiple enzyme systems. Additional studies suggested that CYP2C, FMO, and peroxidase
metabolism of 3,5-DCA contributes to the bioactivation of 3,5-DCA to cytotoxic metabolites. In
order to determine the ultimate toxic species, five putative metabolites were tested for their
nephrotoxic potential. Of the five metabolites tested, only one, 3,5-DCAA was non-toxic.
Further explorations were conducted to identify and quantify metabolites in IRCC after exposure
to 3,5-DCA via HPLC analysis. The results of the HPLC studies show very little metabolism of
3,5-DCA in isolated renal cortical cells, which suggests that the ultimate toxicant is highly
cytotoxic and most likely produced near its cellular target(s). However, the mechanism of 3,5DCA induced cell death and cellular target remains to be determined.
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CHAPTER I: AN IN-DEPTH REVIEW OF ANILINE AND ITS CHLORINATED
DERIVATIVES

1.1 ANILINE AND CHLOROANILINE USE AND ROUTES OF EXPOSURE
Aniline and its mono- and dichlorinated derivatives have been used as chemical
intermediates in the production of multiple agricultural, industrial, and pharmaceutical products.
Aniline itself was first discovered in the early 1800s from indigo distillation and was produced
following the reduction of nitrobenzene, although aniline was called crystallin or cyanol at the
time. It wasn’t until 1843 that Dr. August Hofmann showed that in fact crystallin and cyanol
were actually the same compound, aniline (Hofmann, 1843). The earliest known use of aniline
was in the production of synthetic dyes (Kahl et al., 2011). A student of Dr. Hofmann, William
Perkins, accidentally produced the first aniline dye mauveine, also known as aniline purple
(Perkin, 1879). The use of aniline dyes lead to one of the earliest studies demonstrating that
aniline exposure can have toxic consequences (Muller, 1887). Currently, the major use of aniline
is in the production of methylene dianiline, which is the precursor used in the production of
urethane polymers (Kahl et al., 2011). The structure of methylene dianiline and aniline can be
seen in figure 1.
Chlorinated anilines have also been shown to be important chemical intermediates in the
manufacture of industrial compounds. For example, chlorhexidine, an antibacterial agent, uses 4chloroaniline in its production (Rose and Swain, 1956). Chlorhexidine is widely used as topical
disinfection to promote the healing of wounds in animals (Sanchez et al., 1988). Two products
utilizing 4-chloroaniline as an intermediate are monolinuron and Pigment Red 184. Monolinuron
is a broad leaf pesticide used to control weeds in potato, leek and French bean fields (Rossoff,
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2002; Milne, 2005). Monolinuron’s structure can be found in figure 1. Propanil, a post-emergent
herbicide used to control weeds in rice and wheat fields, is synthesized from 3,4-dichloroaniline
(Warren and Wyatt 2008). Vinclozolin, iprodione, and dimetaclone are all agricultural
fungicides, which contain a 3,5-dichloroaniline moiety. The structure of each can be found in
figure 1. These products highlight just a few uses of aniline and its chlorinated derivatives.
Generally, exposure to large amounts of pure chloroaniline only occurs in industrial
settings, accidental poisonings, or suicide attempts. Exposure to high levels of pure chloroaniline
leads to a variety of toxic conditions, which will be discussed in a later section. However, studies
have suggested that chloroaniline exposure can also occur in smaller amounts via multiple
environmental routes. Demers and Yates (1977) showed that chemical degradation of two
common antimicrobial compounds, 3,4,4’-trichlorocarbanilide and 4,4’-dichloro-3(trifluoromethyl) carbanilide, found in deodorant bars yielded 4-chloroaniline and 3,4dichloroaniline. Chloroanilines have also been detected in soil following the microbial
degradation of pesticides (Bartha and Pramer, 1967; Bartha, 1968; Kearney and Plimmer, 1972;
You and Bartha, 1982). Khan, Marriage, and Saidak (1976) demonstrated that low levels of 3,4dichloroaniline, a microbial breakdown product of Diuron, persisted in soil samples after
treatment with Diuron. 3,5-Dichoroaniline is the major microbial breakdown product of two
carboximide fungicides, iprodione and vinclozolin, in soil (Campos et al., 2015; Walker, 1987a,
1987b). Chlorinated anilines have also been found in groundwater (Wegman and de Korte, 1981)
and industrial runoff (Lyons, Katz, and Bartha, 1984, 1985). Exposure to chlorinated anilines has
been explored in great detail and results in hematotoxicity, splenotoxicity, and of most interest to
the current work in our lab, nephrotoxicity.
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Figure 1. Chemical structure of aniline and related products
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1.2 HEMATOTOXICITY OF ANILINE AND CHLOROANILINES
The major type of hematotoxicity seen following exposure to chlorinated anilines is
methemoglobinemia. Methemoglobinemia occurs when the iron in the heme of hemoglobin is
oxidized to the ferric (Fe3+) form. This oxidation of the heme iron results in the formation of
methemoglobin, and greatly reduces the ability of the blood to transport oxygen. The inability of
methemoglobin to carry oxygen throughout the body can lead to varying degrees of cyanosis.
Under normal physiological conditions, methemoglobin is present in the blood at concentrations
less than 2%; however, levels up to 20% can be tolerated fairly well. Once the concentration of
methemoglobin reaches greater than 70%, death can occur. Methemoglobinemia can be
hereditary or acquired. Hereditary methemoglobinemia is the result of a deficiency in NADH
cytochrome b5 reductase, the enzyme responsible for converting non-functioning
methemoglobin to functioning hemoglobin. In contrast, acquired methemoglobinemia occurs
following exposure to exogenous compounds. The treatment for acquired methemoglobinemia is
the infusion of methylene blue, whose mechanism requires NAD or NADPH dependent
methemoglobin reductase to reduce methemoglobin to hemoglobin (Nascimento, Pereira, de
Mello, and Costa, 2008; Udeh, Bittikofer, and Sum-Ping, 2001). Careful attention must be paid
to the concentration of methylene blue infused as a treatment for methemoglobinemia because at
higher concentrations methylene blue can promote methemoglobin formation; resulting in a
more severe methemoglobinemia and hemolytic anemia (Liao, Hung, and Yang, 2002).
Methemoglobinemia, as a consequence of aniline exposure, was first described in 1959
(Ramsey and Harvey, 1959). In this study, 17 newborn babies presented with
methemoglobinemia after dermal exposure to diapers marked with aniline dye. These newborns
presented with cyanosis and accelerated respiration. In some of the newborns, distention,
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jaundice, enlargement of the spleen, hematuria, loose stool, and vomiting were also present.
While exposure to aniline is the classic example of chemically induced methemoglobinemia,
studies with p-chloroaniline in animals suggest that the p-chloroaniline is even more potent as a
hematotoxicant than aniline (Nomura, 1975). Induction of severe methemoglobinemia has been
well documented in case studies where workers were exposed to p-chloroaniline (Scotti and
Tomasini, 1966; Faivre, Armand, Evreux, Duvermeuil, and Colin, 1971). For example, Pizon et
al. (2009), examined a case where a 20-year old worker, whose job was to remove unknown
waste from barrels and place the waste in an incinerator, was found cyanotic, lethargic, and in
respiratory distress. By the time the worker was examined at the hospital, he was in a coma and
had a methemoglobin level of 69%. Following three hours of methylene blue administration and
mechanical ventilation, the patient recovered. Since the agent responsible for his condition was
unknown, a comprehensive urine drug analysis was performed using GC/MS. Results of the
urine analysis showed detectable levels of p-chloroaniline and p-chloroacetanilide, a known
metabolite of p-chloroaniline, suggesting that the methemoglobin was caused to exposure to pchloroaniline.
Valentovic et al. (1997) showed that acute exposure to 3,5-dichloroaniline was able to
induce methemoglobinemia in male Fischer 344 rats. In this study, a single intraperitoneal (i.p)
injection of 0.8 mmol/kg 3,5-dichloroaniline induced methemoglobinemia levels, which peaked
at two hours post injection and returned to control levels after eight hours. Valentovic et al.
(1997) also explored the ability of two putative metabolites of 3,5-dichloroaniline, 4-amino-2,6dichlorophenol and 3,5-dichlorophenylhydroxylamine, to induce methemoglobinemia, since
previous studies suggested that N-hydroxylated metabolites of aniline are responsible for the
aniline-induced methemoglobinemia (Harrison and Jollow, 1987; Jenkins, Robinson, Gellatly,
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and Slamond, 1972). In vitro studies using freshly isolated washed erythrocytes from male
Fischer 344 rats showed that 3,5-dichloroaniline was able to induce methemoglobin formation
after 60 minutes at concentrations greater than 4 mM. In contrast, 4-amino-2,6-dichlorophenol, a
putative metabolite of 3,5-dichloroaniline, was able to generate methemoglobin in a
concentration dependent manner after a 30 minute exposure at concentrations greater than 0.2
mM. Finally, 3,5-dichlorophenylhydroxylamine, a putative N-hydroxylation metabolite of 3,5dichloroaniline, raised methemoglobin levels significantly after 30 minutes with concentrations
greater than 2 µM (Valentovic et al., 1997). These studies were the first to introduce the idea that
metabolites of aniline and its chlorinated derivatives can lead to increased toxicity and that the
N-hydroxylation biotransformation pathway, which will be discussed later, may be critical in
aniline and chloroaniline-induced methemoglobinemia.
Finally, severe methemoglobinemia following exposure to aniline can also result in
hemolytic anemia (Bus and Popp 1987; Khan, Boor, Alcock, and Ansari, 1997a). Hemolytic
anemia is when abnormal hemolysis of the red blood cells occurs, and this hemolysis is believed
to play a critical role in the splenotoxicity.

1.3 ANILINE- AND CHLOROANILINE-INDUCED SPLENOTOXICITY
Splenotoxicity of aniline and some of its chlorinated derivatives have been documented
in several animal species. Chhabra, Thompson, Elwell, and Gerken (1990), explored the toxicity
of p-chloroaniline in rats (male and female Fischer 344 rats; seven weeks old) and mice (male
and female B6C3F mice; nine weeks old) following exposure to p-chloroaniline (5, 10, 20, 40, or
80 mg/kg body weight for rats; 7.5, 15, 30, 60, or 120 mg/kg body weight for mice) in water, via
oral gavage once daily, five days a week for 13 weeks. Results of this study showed a significant
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increase in spleen weight, which was observed in a dose dependent manner in both rats and mice.
Brain, lung, kidney, heart, thymus, and testis weights were unchanged in the p-chloroaniline
treated groups. An increase in both incidence and severity of extramedullary hematopoiesis and
pigmentation of the spleen was significantly higher than in the control group. This study
supported previous studies in rats, which showed significant splenomegaly, as marked by
congestion, pigmentation, and hematopoiesis, following treatment with aniline or p-chloroaniline
(Gralla, Bus, Reno, Cushman, and Ulland, 1979; Bus, 1983). All of these studies suggested that
the splenotoxicity observed following exposure to aniline or p-chloroaniline was a secondary
consequence of hematotoxicity and increased deposition of damaged erythrocytes in the spleen.
Since one of the major functions of the spleen is to remove aged and/or damaged erythrocytes,
further studies by Khan, Kaphalia, Boor, and Ansari (1993) explored in more detail the
relationship between hematoxicity and splenotoxicity. In this study, male Sprague-Dawley rats
were given 600 ppm of aniline hydrochloride in drinking water for 30, 60, or 90 days. Similar to
the previous studies, significant increases in spleen weight were observed after exposure to
aniline. Red blood cell counts showed significant decreases at all three time points, and
methemoglobin levels were significantly higher. Histological changes were only observed in the
spleen and were marked by increased splenic sinusoids, fibroblasts, macrophages, and
congestion of blood vessels in a time dependent manner. Spleen sections were stained for iron
and showed significant accumulation of iron in a time dependent manner, with the greatest
accumulation of iron seen after 90 days exposure. Additional studies also showed significant
accumulation of iron in rats treated with aniline (Khan et al., 1993, 1997a; Khan, Kaphalia,
Ansari, and Boor 1995a; Khan, Boor, Kaphalia, Alcock, and Ansari1995b; Khan, Wu, Kaphalia,
Boor, and Ansari 1997b). Based on these studies, it was hypothesized that the accumulation of
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damaged erythrocytes would lead to a deposition of iron in the spleen resulting in the generation
of oxidative stress (Stadtman and Oliver, 1991 and Britton, 1996). The increase in oxidative
stress would then contribute to aniline-induced splenotoxicity. Khan et al., (1997a, 1997b; Khan,
Wu, Boor, and Ansari 1999) showed significant increases in oxidative stress markers, such as
lipid peroxidation, following both acute (single i.p. injection) and subchronic exposure to aniline.
These studies confirmed that lipid peroxidation and protein oxidation are critical to anilineinduced splenotoxicity.
A few studies have also shown that chronic exposure to aniline or p-chloroaniline
resulted in a dose-dependent increase in splenic fibrosarcoma tumor formation in rats (Goodman,
Ward, and Reichardt, 1984; Weinberger, Albert, and Montgomery, 1985). Khan et al. (1999)
showed splenic development of fibrotic lesions and hyperplasia, a potential precursor to
tumorgenesis, but no tumor formation was observed. Lipid peroxidation and oxidative damage
has been shown to promote fibrogenesis by over expressing fibrogenic cytokines and increasing
transcription and translation of collagen in animals and humans (Poli and Parola, 1996; Chojkier,
Houglum, Solis-Herruzo, and Brenner, 1989; Geesin, Brown, Gordon, and Berg, 1993).
However, the role of oxidative damage and lipid peroxidation in aniline- and chloroanilineinduced splenic tumorgenesis has yet to be determined in detail.

1.4 ANILINE- AND CHLOROANILINE-INDUCED HEPATOTOXICITY
There have been very few studies which have explored aniline- and chloroanilineinduced hepatotoxicity. One of the earliest reported cases of hepatotoxicity following exposure
to aniline occurred in Madrid, Spain in 1981. From early May 1981 through late June 1981
several thousand patients presented to local hospitals with symptoms that presented as common
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pneumonia. However, it was quickly determined that the symptoms were the result of
contaminated rapeseed oil, which was denatured with aniline, and sold as olive oil. In a subset of
patients, 170 children were admitted to the Hospital Clinico of the Complutense University
Medical School after being exposed to the rapeseed oil. These patients were examined and it was
determined that 55% of the children presented with hepatomegaly as a result of exposure to the
aniline-contaminated oil (Casado de Frias, Andujar, Oliete, and Diaz, 1983). This was the first
study that suggested aniline exposure could lead to hepatotoxicity.
Chhabra et al. (1990) showed increased Kupffer cell pigmentation and hematopoiesis in
rat liver following exposure to p-chloroaniline. In the study, both male and female rats were
exposed to various doses of p-chloroaniline (0, 5, 10, 20, 40, or 80 mg/kg) via oral gavage
(once/day; five days/week; 13 weeks). The results showed increased Kupffer cell pigmentation at
doses greater than or equal to 20 mg/kg in male rats and at doses greater than or equal to 10
mg/kg in female rats. Further studies were conducted by Valentovic et al. (1992) comparing the
hepatotoxicity of aniline, 2-fluoroaniline (2-FA), 2-chloroaniline (2-CA), 2-bromoaniline (2BrA) and 2-iodoaniline (2-IA). In these experiments, male Fischer 344 rats (four per group) were
injected with a single i.p. injection of the hydrochloride salt of aniline, a 2-haloaniline (1.0 or
1.25 mmol/kg) or vehicle (0.9% saline, 2.5 ml/kg). Rats receiving an i.p. injection of vehicle
were pair-fed with the groups receiving the aniline or 2-haloaniline in order to eliminate
variability based on food intake. Alanine aminotransferase (ALT/GPT) activity, liver weight, and
histological examinations were conducted 24-hours post treatment. Liver weight was unchanged
in the 2-FA, 2-ClA and 2-BrA groups, as well as in the 1.25 mmol/kg aniline group, and 1.0
mmol/kg 2-IA groups, when compared to the corresponding pair fed control groups. Significant
increases in liver weight were seen in the 1.0 mmol/kg aniline and 1.25 mmol/kg 2-IA treated
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groups. ALT/GPT activity was significantly elevated in all 2-haloaniline treated groups, but not
in the aniline treated groups. Similarly, histological examination demonstrated dose-dependent
congestion, centrilobular degeneration, and reactive nuclei present after exposure to 2haloanilines. No histological changes were seen following exposure to aniline. This data suggests
that halo-substitution leads to increased hepatotoxicity, although further studies are required to
determine the mechanism of hepatotoxicity.
1.5 ANILINE- AND CHLOROANILINE-INDUCED NEPHROTOXICITY
Although symptoms of renal damage following exposure to aniline and aniline
derivatives had been documented as early as 1945 (Graubarth, Bloom, Coleman, and Solomon,
1945), it was not until the mid 1980s that studies were conducted to determine the nephrotoxic
potential of aniline and chloroanilines. One of the earliest studies looked at the nephrotoxic
potential of aniline, 2-chloroaniline, 3-chloroaniline, and 4-chloroaniline in male Fischer 344 rats
after a single intraperitoneal (i.p.) injection and in a renal cortical slice model (Rankin et al.,
1986a). Food intake, water intake, urine volume and content, blood urea nitrogen (BUN)
concentration, histological examination of kidneys, and renal organic ion transporter function
were assessed to determine nephrotoxic potential after 24 and/or 48 hours post injection. The
results of the in vivo studies showed that of the compounds tested, 2-chloroaniline was
nephrotoxic at 1.0 mmol/kg (single i.p. injection) as evident by increased BUN concentrations 48
hours post injection, decreased urine volume after 24 hours, and decreased organic ion transport.
3-Chloroaniline and 4-chloroaniline required 1.5 mmol/kg to elicit similar nephrotoxic effects. In
contrast, aniline treatment induced very few renal effects, even at doses up to 1.5 mmol/kg. This
study was the first to suggest that chlorine derivatives of aniline possessed enhanced nephrotoxic
potential.
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Around the same time, similar studies exploring the nephrotoxic potential of chlorine
substitution on N-phenylsuccinimides were conducted. It was shown in those studies that
increasing the number of chlorines on the aromatic ring led to an increased nephrotoxic potential.
Of the chlorine substituted N-phenylsuccinimides tested, N-(3,5-dichlorophenyl) succinimide
(NDPS) possessed the greatest nephrotoxic potential (Rankin et al., 1985; Yang, Lahoda, Brown,
and Rankin, 1985a, 1985; Lo, Yang, Lahoda, and Rankin, 1985). Based on the toxicity and
metabolism of NDPS (Ohkawa, Hisada, Fujiwara, and Miyamoto, 1974), it was hypothesized
that 3,5-dichloroaniline, a known metabolite of NDPS, might be even more potent as a
nephrotoxicant than the mono-chlorinated anilines previously tested. To test this hypothesis,
Rankin, Yang, Teets, Lo, and Brown (1986) explored the nephrotoxic potential of 3,5dichloroaniline in male Sprague-Dawley rats. The results showed that a single i.p. injection of
3,5-dichloroaniline (0.8 mmol/kg) was able to produce nephrotoxicity similar to that seen with
the mono-chlorinated anilines previously explored. Specifically, decreased urine output was
evident 24 hours post injection, while increased BUN concentrations and decreased basal and
lactate-stimulated p-aminohippurate (PAH) accumulation by renal cortical slices was seen 48
hours post injection. Histological examination of exposed kidneys 48 hours post injection
showed increased swelling in the proximal tubular cells. These effects were seen at a 3,5dichloroaniline concentration of 0.8 mmol/kg, less than what was required for the monochlorinated derivatives already discussed. Another important difference in this study was the
model used. Sprague-Dawley rats are less sensitive to nephrotoxicants, as compared to the
Fischer 344 rat (Mazze, Cousins, and Kosek, 1973; Kosek, Mazze, and Cousins, 1974;
McMurtry, Snodgrass, and Mitchell, 1978). Since 3,5-dichloroaniline was more nephrotoxic than
the most toxic mono-chlorinated anilines in a less sensitive model it was concluded that, as with
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the N-phenylsuccinimides, increasing the number of chlorines on the aromatic ring leads to
increased nephrotoxicity.
Further studies were conducted to explore the nephrotoxic potential of the six
dichlorinated aniline isomers, to determine the role of chlorine position in nephrotoxic potential.
Also of interest in these studies was the ability of the dichlorinated anilines to induce
nephrotoxicity directly to the kidney using a rat renal cortical slice model (Lo, Brown, and
Rankin, 1990). To determine the in vivo nephrotoxic potential of each isomer, renal function of
male Fischer 344 rats administered one of the dichloroaniline isomers (0.4, 0.8, or 1.0 mmol/kg;
single i.p. injection) was monitored 24 and 48 hours post injection. In general, exposure to
dichloroanilines resulted in increased proteinuria, hematuria, BUN concentration, and decreased
PAH accumulation and urine volume, with the greatest changes seen after exposure to 3,5dichloroaniline. Histological examination of renal tissue showed moderate to severe damage to
the proximal tubular cells following exposure to most of the dichlorinated isomers, with 3,5dichloroaniline (0.8 mmol/kg) producing the most severe effects, as determined by the number of
cells involved and the extent of damage. Damage to the distal tubular cells and collecting ducts
was negligible following exposure to most of the isomers and the glomeruli and loops of Henle
were unaffected. This evidence further supported that the proximal tubular cells are the major
target of chloroaniline-induced nephrotoxicity. The results of the in vivo study showed that 3,5dichloroaniline was the most nephrotoxic dichloroaniline, followed by 2,5-dichloroaniline. 2,4-,
2,6-, and 3,4-Dichloroaniline were next and all possessed the same nephrotoxic potential, while
2,3-dichloroaniline proved to be the least potent nephrotoxicant of the dichlorinated aniline
isomers.
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To assess the in vitro nephrotoxic potential of the dichloroanilines, renal cortical slices
from male Fischer 344 rats were exposed to various concentrations of each dichlorinated aniline
isomer (0-10-3 M) for 120 minutes. Basal and lactate-stimulated PAH and tetraethylammonium
(TEA) accumulation were used as a marker of in vitro renal function. Under normal conditions,
PAH and TEA are accumulated in renal slices to intracellular levels approximately five-fold
higher than the media concentration (Groves, Sheevers, and McGuiness, 1994). Results of Lo et
al. (1990) showed that PAH (basal and lactate-stimulated) and TEA accumulation were
significantly decreased at 10-3 M DCA concentrations of all six isomers in renal cortical slices.
3,5-Dichloroaniline resulted in the greatest decrease at this concentration and was also able to
significantly decrease basal PAH accumulation at the 10-4 M concentration. As seen with the in
vivo study, 3,5-dichloroaniline possessed the greatest nephrotoxic potential (Lo et al, 1990).
These studies suggest that 3,5-dichloroaniline is the most nephrotoxic chlorinated aniline among
the mono- and di-chlorinated anilines, and can be used as a prototypical compound to further
understand chloroaniline-induced nephrotoxicity, since the nephrotoxic profile is similar among
the chlorinated anilines.

1.6 XENOBIOTIC BIOTRANSFORMATION
One principle mechanism that organisms use to maintain homeostasis following exposure
to exogenous molecules, also known as xenobiotics, is biotransformation. Biotransformation is
facilitated by a number of xenobiotic metabolizing enzymes. These xenobiotic metabolizing
enzymes have a wide range of both endogenous and exogenous substrates, and the reactions they
catalyze can be separated into two main categories as first described by Richard Tecwyn
Williams; phase I and phase II reactions (Williams 1959). The enzymes and the reactions they
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catalyze were originally described as “detoxification” enzymes, because the reactions catalyzed
resulted in increased compound hydrophilicity, which promotes the excretion and, ultimately,
removal of the xenobiotic from the body. However, Williams suggested that in some instances
“bioactivation” could occur following both phase I and phase II metabolism. Bioactivation
occurs when xenobiotic metabolism results in a more physiologically active metabolite. The
pharmaceutical industry has utilized bioactivation in drug development for a number of years,
generally to increase bioavailability. Drugs, which require bioactivation, are known as prodrugs.
One example of a prodrug is codeine, which is metabolized via both cytochrome P450 and UDPglucuronosyltranferases. Cytochrome P450 2D6 is the major enzyme responsible for converting
codeine to morphine (Dayer, Desmeules, Leemann, and Striberni, 1988). Another example of a
commonly used prodrug is cyclophosphamide, which is converted to the active metabolite 4hydroxycyclophophamide by liver CYPs. However, in some cases, bioactivation can result in
increased toxicity as is seen with acetaminophen. Cytochrome P450 metabolism of
acetaminophen to the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) is
responsible for acetaminophen-induced hepatotoxicity (Laine, Auriola, Pasanen, and Juvonen,
2009). Metabolizing enzymes are widely distributed throughout the body and levels of phase I
and phase II enzymes can differ not only between tissues, but also within cellular compartments.
Table 1 shows a list of phase I and phase II reactions, enzymes and cellular locations. While the
liver has the highest concentration of phase I and phase II enzymes, these enzymes have been
found in most other tissues, including the kidney.
Phase I reactions, also known as functionalization reactions, result in a slight increase in
the hydrophilicity of a compound by exposing or introducing various functional groups (-OH, SH, -NH2, or -COOH). Sulfation, glucuronidation, acetylation, glutathione conjugation, amino
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acid conjugation, and methylation are all examples of phase II reactions. Phase II reactions can
result in substantial changes in compound hydrophilicity by conjugation of endogenous cofactors
to functional groups either on the non-metabolized parent compound or groups introduced via
phase I metabolism. In the following sections, we will explore in more detail a few important
phase I and phase II enzyme-mediated reactions in aniline and chloroaniline metabolism.
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Table 1. Summary of phase I and phase II reactions, enzymes, and cellular location.
REACTION

ENZYME

LOCATION

Phase I
Hydrolysis
Reduction

Oxidation

Esterase
Microsomes, cytosol, lysosomes, blood
Peptidase
Blood, lysosomes
Epoxide hydrolase
Microsomes, cytosol
Azo- and nitro-reduction
Microflora, microsomes, cytosol
Carbonyl reduction
Cytosol, blood, microsomes
Disulfide reduction
Cytosol
Sulfoxide reduction
Cytosol
Reductive dehalogenation
Microsomes
Alcohol dehydrogenase
Cytosol
Aldehyde dehydrogenase
Mitochondria, cytosol
Aldehyde oxidase
Cytosol
Xanthine oxidase
Cytosol
Monoamine oxidase
Mitochondria
Diamine oxidase
Cytosol
Prostagladin H synthase
Microsomes
Flavin-monooxygenases
Microsomes
Cytochrome P450
Microsomes
Phase II
Glucuronide conjugation
Microsomes
Sulfate conjugation
Cytosol
Glutathione conjugation
Cytosol, microsomes
Amino acid conjugation
Mitochondria, microsomes
Acylation
Mitochondria, cytosol
Methylation
Cytosol, microsomes, blood
Information from Parkinson (2001).
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1.7 CYTOCHROME P450 (CYP)
Cytochrome P450s (CYPs) are a super family of heme-containing proteins and represent
the largest group of phase I reaction enzymes, both in number of substrates and number of
isoforms (Guengerich, 1987; Waterman and Johnson 1991). Cytochrome P450s were first
identified and characterized as a single enzyme found in the endoplasmic reticulum of rabbit
liver able to oxidize xenobiotic compounds in 1955 by Axelrod (1955) and Brodie et al. (1955).
Additional studies showed that this enzyme had a maximum absorbance at 450 nm due to its
ability to bind CO (Garfinkel 1958; Klingenberg 1958). Further studies demonstrated that this
enzyme was a hemoprotein and was named cytochrome P450 (CYP) after its absorbance (Omura
and Sato 1964a, 1964b). Since those earlier studies, there are now more than 6000 known
isoforms of CYP, in all species, (Macherey and Dansette, 2008), which are named and grouped
based on amino acid sequencing similarities (Gonzalez, 1989; Nelson et al., 1993). Cytochrome
P450 enzymes with amino acid sequence similarity of 40 percent or less are separated into
multiple gene families, represented by the number immediately following CYP (i.e., CYP1,
CYP2, etc). The CYPs are then further separated in subfamilies with conserved amino acid
sequence between 40-55 percent and are designated by a letter (i.e, CYP1A, CYP1B, etc.).
Finally, if 55 percent or more of the amino acid sequence is similar, then the CYP is classified as
members of the same subfamily (i.e. CYP1A1, CYP1A2, etc.). Since the nomenclature is based
on amino acid structure rather than function or evolutionary relationship, CYPs are named in a
amino acid sequence sequential manner. For example, CYP2A6 is the only functional CYP2A in
human liver and CYP2A1 is the member of the CYP2A subfamily found in mouse. CYP1A1,
CYP1A2, CYP1B1, and CYP2E1 are the only exception to the nomenclature as the function and
regulation is highly conserved across all mammalian species (Parkinson, 2001).
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The expression and activity of CYPs are affected by both genetic and environmental
factors. Genetic polymorphisms have been shown in a number of CYPs. These polymorphisms
can lead to significant changes in the CYP metabolism of xenobiotics. CYP2D6 is one such
CYP. The CYP2D6 family is important in the metabolism of a number of drugs, including
codeine, tamoxifen, and antidepressants. Polymorphisms within the CYP2D6 allele lead to up to
four groups of patients that can be grouped based on their ability to metabolize CYP2D6
substrates. The three groups are poor metabolizers, normal metabolizers, and ultrarapid
metabolizers. Of the Caucasian population, 6-10% fall within the poor metabolizer group, due to
the presence of a CYP2D6 allele with decreased function, while ~2% of the Asian population are
poor metabolizers (Bradford, 2002). In contrast, Middle Eastern and North African populations
tend to have more ultrarapid metabolizers (McLellan, Oscarson, Seidefard, Evans, and IngelmanSundberg, 1997) within the population.
Environmental factors, which can affect CYP expression and activity, are social habits
(smoking, alcohol consumption), foods (cruciferous vegetables), medications (isoniazid,
barbiturates), and disease states (pregnancy, diabetes). The discovery that medicines and other
environmental factors can alter CYP activity has allowed researchers to search for compounds
that can inhibit CYP metabolism altogether. These CYP inhibitors have become useful in
determining the metabolism of xenobiotics. CYP inhibitors can have isoform selective or nonselective activity, and these differences can also be species specific. For example, ketoconazole
has been shown to be a potent CYP3A4 inhibitor in humans, but has much less isozyme selective
activity in rats (Eagling, Tijia, and Back, 1998). The species specific differences in CYP
inhibition is most likely due to differences in the CYP catalytic and/ or binding sites between
species. For this reason caution must be taken when extrapolating results between species
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(Spatzenegger, Born, and Halpert, 2003). Table 2 shows the species which is most similar to
humans in terms of CYP activity.
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Table 2. Species with CYP activity most comparable to humans.
Human P450

Species Most Similar

CYP1A1

Rat, Rabbit

CYP1A2

Rat, Mouse

CYP2A6

Monkey, Mouse, Hamster, Rabbit

CYP2B6

Mouse

CYP2C19

Monkey

CYP2D6

Dog

CYP2E1

No large species differences

CYP3A4

Mouse, Male Rat

CYP4A11

No large species differences
Data adapted from Spatzenegger et al (2003).
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CYPs are found in the greatest concentration in the endoplasmic reticulum of liver
tissues; however, they have also been found in other tissues such as lung, skin, blood, and
kidneys. In humans, CYP1A1, CYP1A2, and CYP4A1 protein isoforms have been found in the
kidney (Ioannides and Parke, 1990; Hardwick, Song, Hubeman, and Gonzalez, 1987). Gonzalez
(1989) found CYP2 and CYP4 family genes are expressed in the human kidney. Finally,
CYP3A4 is expressed in approximately 80 percent of human kidneys. In contrast, Cummings,
Zangar, and Novak (1999) demonstrated that freshly isolated renal proximal and distal tubular
cells from male Fischer 344 rats expressed CYP2E1, CYP2C11, CYP2B1/2, and CYP4A3/4.
CYP4A2 is also present in rat kidneys (Kimura, Hanioka, Matsunga, and Gonzalez, 1989a;
Kimura, Hardwick, Kozak, and Gonzalez, 1989b).
CYPs are responsible for 75-80% of all phase I metabolism (Nelson, 2004; Guengerich,
2008; Zanger, Turpeinen, Klein, and Schwab, 2008). CYP enzymes catalyze monooxygenase
reactions, where one atom of molecular oxygen is added to the substrate, and a second atom of
oxygen is reduced to water with reducing equivalents from NADPH. In the endoplasmic
reticulum, the electron from NADPH is enzymatically transferred to the CYP enzyme via
NADPH-cytochrome P450 reductase. The general reactions for CYP can be expressed as
Substrate (RH) + O2 + NADPH + H+ è

Product (ROH) + H2O + NADP+. Figure 2 shows the

cyclic catalytic nature of CYP reactions (Dawson, 1988; Schlichting, 2000). While CYPs
catalyze a number of oxidation reactions, two are important reactions in aniline and chloroaniline
metabolism: aromatic ring hydroxylation and N-hydroxylation. The role of these reactions in
aniline and its chlorinated derivative biotransformation will be explored in more detail in a later
section.
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Figure 2. Cytochrome P450 Catalytic Cycle. The substrate is RH and the oxidized substrate is
ROH.
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1.8 FAD-CONTAINING MONOOXYGENASES (FMOs)
Another key phase I xenobiotic metabolism enzyme system is the flavin adenine
dinucleotide (FAD)-containing monooxygenase (FMO) enzymes. First discovered in the early
1970s in pig liver by Dr. Daniel Ziegler, FMOs were described as a single flavoprotein enzyme
that was able to oxidize a number of amines to nitro compounds (Ziegler, 1980). There are now
five known mammalian FMO isozymes, designated as FMO1, FMO2, FMO3, FMO4, and
FMO5 (Lawton et al., 1994; Cashman, 1995, 1999; Van Berkel, Namerbeek, and Fraaije, 2006).
FMOs are located in the endoplasmic reticulum of almost all tissues including the liver, lungs,
and kidney. Similar to the cytochrome P450s discussed earlier, species and tissue specific
differences in expression have been explored in some detail. A summary of these studies can be
found in table 3. For example, FMO1 has been shown to be expressed at high levels in the
human kidney, but very low in human liver. In contrast, FMO1 expression is high in both rat
kidney and liver tissue (Cashman, 1995; Dolphin et al., 1991; Parkinson, 2001). Along with
FMO1, FMO2 and FMO4 are expressed at high levels in rat kidneys (Cashman, 1995). While
differences occur in expression, the amino acid sequence for the five mammalian isozymes are
50-58% identical, with each FMO having two highly conserved regions near the active site, one
that binds the FAD moiety and the second that binds NADPH (Phillips et al., 1995; Kubo, Itoh,
Itoh, and Kamataki, 1997; Lawton and Philpot, 1993).
Ziegler discovered that the FAD moiety bound to the enzyme in the presence of oxygen
forms a 4α-hydroxyperoxyflavin intermediate (Ziegler 1980). This 4α-hydroxyperoxyflavin is
uncharacteristically stable for a peroxyflavin, which allows it to oxygenate substrates (Entsch
and van Berkel, 1995). Figure 3 shows the catalytic cycle of FMOs, starting with the reduction of
FAD to FADH2 by NADPH, which in the present of O2 generates the 4α-hydroxyperoxyflavin.
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4α-Hydroxyperoxyflavin is then converted to 4α-hydroxyflavin as the flavin peroxide is
transferred to the xenobiotic substrate. Finally, 4α-hydroxyflavin is dehydrated and NADP+ is
released, resetting the FAD moiety of the enzyme, priming it to react again (van Berkel et al,
2006). Most FMO substrates are soft nucleophile heteroatoms (nitrogen or sulfur containing
compounds) and undergo N-oxidation or sulfoxidation; although hydroxylation, epoxidation,
selenide oxidation, and phosphate ester oxidation can be catalyzed by FMOs (van Berkel et al.,
2006; Jokanovic, 2001; Rooseboom, Commandeur, Floor, Rettie, and Vermeulen, 2001; Lohr,
Willsky, and Acara, 1998). A few substrates and reactions catalyzed by FMO can be seen in
Figure 4. Benadryl, imipramine, nicotine, morphine, and chlorpromazine are all examples of
drugs that have been shown to form N-oxide metabolites (Lohr et al., 1998). The N-oxide
metabolite of meperidine was the major metabolite in perfused isolated rat kidney (Acara,
Gessner, Greizerstein, and Trudnowski, 1981). While the majority of FMO substrates are tertiary
amines, there has been evidence in support of FMO oxidation of primary amines (Tynes ,
Sabourin, Hodgson, and Philpot, 1986).
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Table 3. Putative tissue levels of FMO forms present in animals and humans. NP, apparently not
present. A question mark indicates that no data are available or the presence of FMO form is in
doubt. Adapted from Cashman, 1995.
FMO1
FMO2
FMO3
FMO4
FMO5
Liver
Mouse
Low
NP
High
?
Low
Rat
High
?
Low
?
Low
Rabbit
High
NP
Low
?
Low
Human Very Low
Low
High
Very Low
Low
Kidney
Mouse
High
?
High
?
Low
Rat
High
?
High
High
Low
Rabbit
Low
Low
Very Low
High
Low
Human High
Low
?
?
?
Lung
Mouse
?
High
Very Low
NP
Low
Rat
?
?
?
NP
Low
Rabbit
?
Very High
?
NP
NP
Human ?
Low
?
NP
?
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Figure 3. FMO Catalytic Cycle. X is the xenobiotic substrate; XO is the oxygenated product;
FADHOOH is the 4α-hydroperoxyflavin; FADHOH is the 4α-hydroxyflavin
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Figure 4. Examples of FMO substrates.
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1.9 PEROXIDASE-DEPENDENT COOXIDATION
Peroxidase cooxidation has been shown to play a role in xenobiotic metabolism,
especially in extrahepatic tissues that have low levels of CYPs. Unlike the other oxidative
biotransformation pathways that require the reduction of cofactors such as NADPH and NADH,
during peroxidase cooxidation the reduction of hydrogen peroxide and other lipid peroxides is
coupled to the oxidation of xenobiotics and other substrates (Eling, Thompson, Foureman,
Curtis, and Hughes, 1990). There are a number of peroxidases, which can catalyze xenobiotic
biotransformation. One of the most commonly studied peroxidases involved in xenobiotic
biotransformation is prostaglandin H synthase (PHS). There are two main pathways for PHSdependent cooxidation. The first involves the direct transfer of peroxide oxygen to the substrate,
while the second utilizes the xenobiotcs as electron donors, which can be oxidized by free
radicals during the reduction of hydrogen peroxide. One example of xenobiotic metabolism by
PHS is the two-electron oxidation of acetaminophen to N-acetyl-benzoquinoneimine. It has been
suggested that a single electron intermediate, N-acetyl-benzosemiquinonemine is formed via
PHS cooxidation. Further studies have suggested that N-acetyl-benzosemiquinonemine
contributes to the nephrotoxicity of acetaminophen. PHS is expressed in kidney medulla, brain,
lung, urinary bladder epithelium, and GI tract (Parkinson, 2001). While peroxidase-dependent
cooxidation has not been shown as a major pathway in aniline and chloroaniline metabolism, it is
a potential pathway whose role needs to be explored in more detail.
1.10 GLUCURONIDE AND SULFATE CONJUGATION REACTIONS
Glucuronidation and sulfation are two major phase II reactions that primarily detoxify
xenobiotics. These reactions require endogenous cofactors to react with functional groups of the
xenobiotics to increase polarity of the parent compound or metabolite, which will increase the
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rate of excretion. As mentioned before, phase II reactions can occur prior to or following phase I
metabolism. It is also important to note the phase II reactions generally occur at a greater rate
than phase I reactions (Parkinson, 2001).
Glucuronidation is catalyzed by UDP-glucuronosyltranferases (UGTs). Initially, UGTs
were separated into four groups; however, it is now apparent that there are only two gene
families, UGT1 and UGT2 (Parkinson, 2001), found in rats. The members of UGT2 can be
further separated into two sub-families, UGT2A and UGT2B. The members of the UGT2 arise
from different genes. In contrast, all members of UGT1 arise from a single gene, with multiple
UGTs encoded. UGTs have been found in the endoplasmic reticulum of the multiple tissues,
including the liver and kidney. In glucuronidation, uridine diphosphate-glucuronic acid (UDPglucuronic acid) is added to electron rich heteroatoms, such as oxygen, nitrogen, or sulfur. Over
350 UGT substrates have been discovered (Tukey and Strassburg, 2000). Figure 5 shows a
sampling of substrates. For example, aniline and its chlorinated derivatives have been shown to
undergo glucuronidation as will be discussed in more detail in the next section (Smith and
Williams, 1949; Bohme and Grunow, 1969; Parke, 1960). Since glucuronidation requires UDPglucuronic acid, UDP-glucuronic acid availability can limit the rate of glucuronidation.
Depletion of UDP-glucuronic acid can lead to increased toxicity, if glucuronidation is the major
detoxifying pathway (Whitcomb and Block, 1994).
Sulfation on the other hand is catalyzed by the cytosolic enzyme sulfotransferase. There
are a number of sulfotranferase enzymes that have been characterized in mammals. While there
is not a universally agreed upon nomenclature, the sulfotranferase enzymes can be separated into
five distinct gene families, SULT1A-SULT1E (Nagata and Yamazoe, 2000). This nomenclature
uses amino acid sequence similarities to group members into one of the five gene families.

29

Sulfotransferase has been found in a number of tissues, including the kidney (Mulder and
Jakoby, 1990). The function of sulfotransferase is to transfer sulfonate from 3’phosphoadenosine-5’-phosphosulfate (PAPS) to the substrate (Figure 5). Some examples of
xenobiotics that undergo sulfation are acetaminophen and phenol. While phenols and aliphatic
alcohols represent the largest group of substrates that are sulfated, a number of aromatic amines
have been shown to be sulfated. Aniline and its chlorinated derivatives have been shown to
undergo both O- and N-sulfation during metabolism (Hong and Rankin, 1998; Parkinson, 2001;
Ehlhardt and Howbert, 1991; Bohme and Grunow, 1969). The metabolism of aniline will be
explored in more detail in the following section.
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Figure 5. Examples of substrates, which undergo glucuronidation and/or sulfation.
Arrow indicates site of glucuronidation or sulfation.
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1.11 ANILINE AND CHLOROANILINE METABOLISM
The biotransformation of aniline has been explored in great detail in both mammalian and
non-mammalian species. One of the first known accounts of human exposure and resulting
metabolism of aniline was a human poisoning case with 25 g of aniline. This study showed that
the patient’s urine contained sulfate conjugated p-aminophenol, as well as unchanged aniline
(Muller 1887). Additional studies where dogs (Schmiedeberg, 1878) and rats (Elson, Goulden,
and Warren, 1946) were fed aniline found similar results to Muller’s results in that the urine
contained p-aminophenol after acid hydrolysis. In 1949, Smith and Williams investigated the fate
of aniline in rabbits. In this study, rabbits were given 200 mg/kg aniline via an oral dose. The
results of the study demonstrated that while conjugated p-aminophenol metabolites represented
40-45% of the aniline fed, the major metabolite was the N-glucuronide of aniline itself (Figure
6). With the availability of [14C]-aniline in the early 60s, it became possible to account for 75100% of a single dose of aniline in rabbits and other animals. The results showed that in rabbits
51% of the dose was eliminated as p-aminophenol, 9% was o-aminophenol, 0.1 % was maminophenol, 3.5% was aniline-N-glucuronide, 5.4% was phenylsulphamic acid, 0.2% was
acetanilide, and finally, 8.2% was eliminated as unchanged aniline (Parke, 1960).
Kao, Faulkner, and Bridges, (1978) provided the next major breakthrough in the
metabolism of aniline. Their study found that the major urinary metabolite of aniline in male
Wistar albino rats was N-acetyl-p-aminophenol sulfate (~56%). Minor metabolites included Oconjugates of o- and p-aminophenol (~20%), acetanilide (~3%) and N-acetyl-p-aminophenol
(~10%), as determined by thin layer chromatography. In contrast to the previous studies already
discussed, neither N-glucuronides and sulfates of aniline, nor free aniline were detected in the
urine. This difference can be explained by the use of enzymatic hydrolysis of sulfate and
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glucuronide conjugates, as opposed to chemical hydrolysis used in previous studies. It is possible
that the strong acids used in the previous studies could lead to deacetylation, as well as
hydrolysis of both the sulfate and glucuronide conjugates (Kao et al., 1978).
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Figure 6. Metabolites of aniline. Information is from Smith and Williams (1949). Percentages
displayed are the percent of dose recovered in urine after rabbits were given 200 mg/kg of aniline
via an oral dose.
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During this same time period, experiments exploring the metabolism of halogenated
anilines were being conducted. The major halogenated aniline explored was the chlorinated
derivative of aniline, p-chloroaniline, sometimes referred to as 4-chloroaniline. In Fischer 344
rats, the major urinary metabolite found was 2-amino-5-chlorophenylsulfate (Ehlhardt and
Howbert, 1991), following a single dose of 4-chloroaniline given intragastrically by syringe. NAcetyl-2-amino-5-chlorophenylsulfate was a minor metabolite and accounted for ~7% of the
dose. Once again, no glucuronides were found in the urine. Since hydroxylation of the paraposition is effectively blocked with the addition of chlorine, the o-hydroxylation and
subsequently conjugated product would be expected to be the major metabolite. Similarly to
aniline metabolism, the ortho-hydroxylated metabolite is excreted as free aniline sulfate rather
than its N-acetylated derivative. In similar studies with 3-chloroaniline, aromatic ring
hydroxylation to 4-amino-2-chlorophenol and 2-amino-4-chlorophenol was the major
biotransformation pathway (Bohme and Grunow 1969). Both of these metabolites were then Nacetylated and/or conjugated to form a sulfate or glucuronide metabolites. These studies have
demonstrated that phenyl ring hydroxylation, N-acetylation, glucuronidation, and sulfonation are
all important metabolic pathways for aniline and chloroaniline metabolism, in vivo.
Another proposed metabolic pathway that has been explored in aniline metabolism is Nhydroxylation. The N-hydroxylation metabolite of aniline, phenylhydroxylamine, has only been
shown in blood (Harrison and Jollow 1986, 1987). Harrison and Jollow (1986) measured the
formation of 2-aminophenol, 4-aminonophenol, 4-hydroxyacetanilide, and phenylhydroxylamine
in the blood of male Sprague-Dawley rats following a single i.p. injection of aniline (1.5
mmol/kg). Phenylhydroxylamine was measured as phenylhydroxyalamine + nitrosobenzene as
previously described (Harrison and Jollow, 1983). The results showed the major unconjugated
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metabolite found in blood for the first five hours post injection was the phenylhydroxylamine +
nitrosobenzene, as measured by HPLC. The peak levels of phenylhydroxylamine occurred just
ten minutes post injection. In contrast, both the 4-aminophenol and 4-hydroxyacetanilide
concentrations did not peak until 6-8 hours post injection. N-Hydroxylation of aniline and
chloroaniline has been shown to play a role in aniline-induced methemoglobinemia, as
previously discussed (Valentovic et al, 1997; Harrison and Jollow, 1987; Jenkins et al., 1972).
While N-hydroxylation metabolites have not been found in urine following exposure to either
aniline or chloroanilines, N-hydroxylation is still a potential biotransformation pathway for these
compounds that needs to be explored in greater detail.

1.12 CHLOROANILINE METABOLITE INDUCED NEPHROTOXICITY
The nephrotoxic potential of select chloroaniline metabolites have been previously
described both in vivo and in vitro (Rankin et al., 1994, 1996; Rankin, Racine, Sweeney,
Kraynie, Anestis, and Barnett 2008a; Valentovic, Ball, Sun, and Rankin, 2002; Hong et al.,
1997). Most of these studies explored the nephrotoxicity of putative metabolites, which arise
from phenyl ring hydroxylation to aminophenolic compounds because 4-aminophenol, the parahydroxylation product of aniline, was shown to cause diuresis, elevated kidney weight, increased
BUN levels, proteinuria, glucosuria, proximal tubular necrosis, and decreased organic ion
accumulation in Fischer 344 and Sprague-Dawley rats (Newton, Kuo, Gemborys, Mudge, and
Hook, 1982; Davis et al., 1983; Gartland, Bonner, Trimbell, and Nicholson, 1989). One of the
few studies to explore the nephrotoxic potential of putative chlorinated anilines was conducted
by Rankin et al. (1994). In that study, male Fischer 344 rats were given a single i.p. injection of
4-amino-2,6-dichlorophenol (0.25, 0.38, or 0.50 mmol/kg). Results of the study show that a
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single i.p. injection of 0.38 mmol/kg 4-amino-2,6-dichlorophenol was able to produce
nephrotoxicity similar to that seen with 3,5-dichloroaniline. The nephrotoxicity was
characterized by significant increases in hematuria, proteinuria, glucosuria, BUN concentration,
and kidney weight, as well as significantly decreasing organic ion accumulation in vivo. In vitro
studies showed significant increases in lactate dehydrogenase (LDH) release, a marker of
cytotoxicity, from renal cortical slices following the exposure to concentrations greater than 1 x
10-5 M for 90 minutes (Rankin et al., 1994). Comparisons with 3,5-dichloroaniline suggest that
the putative metabolite, 4-amino-2,6-dichlorophenol, is a more potent nephrotoxicant than 3,5dichloroaniline (Rankin et al., 1994). However, further studies are required to determine the role
of 4-amino-2,6-dichlorophenol and other putative 3,5-dichloroaniline metabolites in 3,5dichloroaniline-induced nephrotoxicity.

1.13 SCOPE OF CURRENT WORK
It was hypothesized that 3,5-DCA would be nephrotoxic in IRCC from male Fischer 344
rats, and that renal metabolism of 3,5-DCA in IRCC contributed to nephrotoxicity, at least in
part. The current studies were designed to explore the metabolism of 3,5-dichloroaniline (3,5DCA), the nephrotoxic potential of 3,5-DCA and its putative metabolites, the role of metabolism
in 3,5-DCA induced nephrotoxicity, and the role of oxidative stress as a mechanism of cell death,
using a Fischer 344 rat isolated renal cortical cell (IRCC) model. 3,5-DCA was chosen for
further exploration because it proved to possess the greatest nephrotoxic potential among the
mono- and dichlorinated anilines, both in vivo and in vitro using rat renal slices, as discussed
above (Lo et al., 1990; Valentovic, Ball, Anestis, and Rankin 1995a; Valentovic et al.,1996).
While most of the previous in vitro work was performed in a renal slice model, the current study
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was performed in IRCC. The IRCC model was chosen because it is enriched for proximal tubular
cells, the major target of 3,5-DCA induced nephrotoxicity. Fischer 344 rats were chosen as the
animal species because they have been shown to respond to nephrotoxicants more like humans
do than other rat strains (Mazze et al., 1973, Kosek et al., 1974; McMurtry et al., 1978).

38
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ABSTRACT
Among the mono- and dichloroanilines, 3,5-Dichloroaniline (3,5-DCA) is the most potent
nephrotoxicant in vivo and in vitro. However, the role of renal biotransformation in 3,5-DCA
induced nephrotoxicity is unknown. The current study was designed to determine the in vitro
nephrotoxic potential of 3,5-DCA in isolated renal cortical cells (IRCC) obtained from male
Fischer 344 rats, and the role of renal bioactivation and oxidative stress in 3,5-DCA
nephrotoxicity. IRCC (~4 million cells/ml) from male rats were exposed to 3,5-DCA (0-1.0 mM)
for up to 120 min. In IRCC, 3,5-DCA was cytotoxic at 1.0 mM by 60 min as evidenced by the
increased release of lactate dehydrogenase (LDH), but 120 min was required for 3,5-DCA 0.5
mM to increase LDH release. In subsequent studies, IRCC were exposed to a pretreatment
(antioxidant or enzyme inhibitor) prior to exposure to 3,5-DCA (1.0 mM) for 90 min.
Cytotoxicity induced by 3,5-DCA was attenuated by pretreatment with inhibitors of flavincontaining monooxygenase (FMO; methimazole, N-octylamine), cytochrome P450 (CYP;
piperonyl butoxide, metyrapone), or peroxidase (indomethacin, mercaptosuccinate) enzymes.
Use of more selective CYP inhibitors suggested that the CYP 2C family contributed to 3,5-DCA
bioactivation. Antioxidants (glutathione, N-acetyl-L-cysteine, α-tocopherol, ascorbate, pyruvate)
also attenuated 3,5-DCA nephrotoxicity, but oxidized glutathione levels and the
oxidized/reduced glutathione ratios were not increased. These results indicate that 3,5-DCA may
be activated via several renal enzyme systems to toxic metabolites, and that free radicals, but not
oxidative stress, contribute to 3,5-DCA induced nephrotoxicity in vitro.
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ALT, alanine aminotransferase; GPT, glutamic-pyruvic transaminase; GSH, glutathione; GSSG,
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2.1 INTRODUCTION
Toxicity arising from exposure to anilines, important chemical intermediates used in the
production of agricultural, industrial and pharmaceutical products (Lindh, Littorin, Amilon, and
Jönsson, 2007; Unger, 1996), has been well established. Exposure to aniline and its chlorinated
derivatives has been associated with hematotoxicity (methemoglobinemia, hemolytic anemia;
Chhabra et al., 1990; Guilhermino, Sores, Carvalho, and Lopes, 1998; Pauluhn, 2004; Valentovic
et al., 1997), splenotoxicity (splenomegaly, elevated erythropoietic activity, hyperpigmentation,
fibrosis; Chhabra et al., 1990; Khan, Wu, Boor, and Ansari, 1999; Ma, Wang, Abdel-Rahman,
Boor, and Kahn, 2008, 2013), hepatotoxicity (hepatomegaly, elevated serum ALT/GPT levels,
centralobular necrosis; Valentovic et al., 1992, 1995a; Valentovic, Lo, Brown, and Rankin,
1995b), and nephrotoxicity (Hong, Anestis, Henderson, and Rankin, 2000; Lo et al., 1990;
Racine et al., 2014; Valentovic et al., 1995a). Chloroaniline induced nephrotoxicity in vivo is
characterized by oliguria, decreased kidney weight, proteinuria, hematuria, elevated blood urea
nitrogen (BUN) concentration, and decreased organic ion transport in the proximal tubule cells
(Rankin et al., 1986; Lo et al., 1990; Valentovic et al., 1995a). Morphological changes occur in
both the proximal and distal tubules and collecting ducts, with the greatest abnormalities seen in
the proximal tubular cells. These morphological changes include blebbing and vacuolization of
proximal tubular cells, occluded lumina with sloughed microvilli and enlarged lumina in the
distal tubule (Lo et al., 1990). In vitro exposure of rat renal cortical slices to chloroanilines leads
to a significant increase in cytotoxicity as seen by a decrease in organic ion accumulation and an
increase in lactate dehydrogenase (LDH) release (Valentovic et al., 1992, 1995a, 1995b). Among
the mono- and dichloroanilines, 3,5-dichloroaniline (3,5-DCA) was the most potent
nephrotoxicant both in vivo and in vitro (Lo et al., 1990; Valentovic et al., 1995a, 1996).
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Biotransformation via N-oxidation, N-acetylation, and phenyl ring oxidation are all known
pathways of chloroaniline metabolism (Ehlhardt and Howbert, 1991; Hong and Rankin, 1998;
Racine et al., 2014). Based on these studies a proposed biotransformation pathway of 3,5-DCA
can be seen in figure 7. Two of these pathways (N-oxidation and phenyl ring oxidation) have the
potential to lead to the formation of toxic metabolites from aniline compounds. For example, Noxidation of aniline leads to toxic metabolites responsible for hematoxicity (Harrison and Jollow,
1987, 1986) and splenotoxicity (Khan, Wu, and Ansari, 2000; Ma et al., 2013, 2008), while
formation of the 4-aminophenol metabolite can contribute to nephrotoxicity (Harmon, Terneus,
Kiningham, and Valentovic, 2005; Rankin et al., 1996; Tarloff, Goldstein, Morgan, and Hook,
1989). A small number of studies have shown that bioactivation can also contribute to the
nephrotoxicity associated with some chloroanilines (Racine et al., 2014; Valentovic et al.,
1995b). Putative metabolites of chloroanilines arising from N-oxidation or phenyl ring oxidation
are also toxic to the kidney (Hong et al., 1997, 1996; Rankin et al., 2008a). Nonetheless, the
enzyme systems responsible for the bioactivation of chloroanilines studied to date and the
ultimate nephrotoxic metabolites formed from these compounds are not clearly defined.
Oxidative stress may contribute to the mechanism of cell death with aniline compounds.
Harmon et al. (2005) found that oxidative stress played a role in 4-aminophenol-induced
nephrotoxicity in vitro, while Hong et al. (1997) showed that in vivo 4-amino-2,6-dichlorophenol
(ADCP), a putative metabolite of 3,5-DCA, increased the oxidized to reduced glutathione ratio in
kidney, suggesting that ADCP induced renal oxidative stress. In addition, ADCP nephrotoxicity
was prevented by pretreatment with antioxidants. However, it is unclear if oxidative stress plays
a role in 3,5-DCA nephrotoxicity.
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Figure 7. Proposed Renal Biotransformation Pathway of 3,5-DCA. Abbreviations:
CYP=Cytochrome P450, FMO=Flavin-containing Monooxygenase, NAT= N-acetyltransferase.
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The purpose of this study was to explore, in more detail, the in vitro nephrotoxicity induced
by 3,5-DCA. The in vitro cytotoxicity of 3,5-DCA was determined in isolated rat renal cortical
cells (IRCC) from male Fischer 344 rats, and the role of renal metabolizing enzyme systems,
including CYP isozymes, in the bioactivation of 3,5-DCA to nephrotoxic metabolites was also
examined. Lastly, the role of free radicals and oxidative stress in 3,5-DCA-induced
nephrotoxicity was explored. The IRCC model was selected for use because this model contains
the target cells for 3,5-DCA and maintains metabolic and transport capabilities seen in vivo for
several hours, including CYP activity (Cummings et al., 1999; Lash, 1998).
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2.2 MATERIALS AND METHODS
2.2.1 Experimental Animals
Male Fischer 344 rats (200-250 g) from Hilltop Lab Animals, Inc. (Scottdale, PA) were
used for these experiments. All animals were kept in a controlled environment with a regulated
light cycle (12 h on/12 h off), temperature (21-23oC), and humidity (40-55%) with food (Purina
Rat Chow) and water available ad libitum. Rats were allowed at least one week to acclimate to
the animal facilities prior to use in any experiments. Animal use for these experiments was
approved by the Marshall University Institutional Animal Care and Use Committee, and animal
use was conducted in accordance with the Guide for the Care and Use of Laboratory Animals as
adopted by the National Institutes of Health.

2.2.2 Chemicals
All chemicals used were the highest purity available and were purchased from Sigma
Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).

2.2.3 Isolated Renal Cortical Cells (IRCC) preparation and treatment
Untreated male rats were anesthetized with pentobarbital (75 mg/kg, ip) and isolated
renal cortical cells (IRCC) were obtained using the collagenase perfusion method of Jones,
Sundby, Ormstad, and Orrenius (1979). Cell viability was initially determined by trypan blue
(2% w/v) exclusion and lactate dehydrogenase (LDH) release. IRCC were counted and
resuspended in Krebs-Henseleit buffer, pH 7.37, containing 25 mM Hepes and 2% (w/v) bovine
serum albumin at a concentration of ~4.2 million cells/ml. IRCC (3 ml) were added to 25 ml
polycarbonate Erlenmeyer flasks for a five min pre-incubation period in a Dubnoff shaking water
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bath incubator (37˚C, 60 cycles/min) under an atmosphere of 95% oxygen and 5% carbon
dioxide. Cells were exposed to various concentrations of 3,5-dichloroaniline (3,5-DCA; 0.5 or
1.0 mM) or vehicle (DMSO) for 60, 90 or 120 min. After the incubation period, flasks were
removed, placed on ice, and samples (0.5 ml) taken for lactate dehydrogenase (LDH) release
assays. Briefly, samples were centrifuged (3000xg, 3 min), the supernatant was decanted and
saved, and the pellet was disrupted with 1 ml of 10% Triton X-100 solution to release cellular
LDH. LDH activity was then determined in each fraction as previously described using a kinetic
assay based on the amount of NADH produced from NAD (Rankin et al., 2008b). LDH released
into the media was expressed as the percent of total (media + pellet).
In separate experiments, IRCC were pretreated with either an antioxidant or an enzyme
system inhibitor (Table 4) before exposure to 1.0 mM 3,5-DCA for 90 min, to determine the role
of biotransformation of 3,5-DCA on cytotoxicity. Males were chosen for these experiments
because our previous studies were performed in male rats (Lo, Valentovic, Brown, and Rankin
1994; Valentovic et al., 1995b). All pretreatment times and concentrations were based on
previously published studies (Baliga, Zhang, Baliga, Ueda, and Shah, 1998; Harleton et al.,
2004.; Harmon et al., 2005; Harmon, Kiningham, and Valentovic, 2006; Katsuda et al., 2010;
Lau and Monks, 1987; Lock, Cross, and Schnellmann, 1993; O’Brien and Siraki, 2005;
Rodriguez and Acosta, 1997; Suzuki and Sudo, 1990; Valentovic et al., 1999).
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Table 4. List of antioxidants and enzyme inhibitors with primary targeted enzyme systems.
Pretreatment (PreTx)
Compound

PreTx
Conc.
2.0mM

PreTx
Time
(min)
30

Mechanism or
Enzyme
Inhibited
Antioxidant

N-Acetyl-L-cysteine
α-Tocopherol

1.0mM

5

Antioxidant

Glutathione
Ascorbate
Pyruvate

1.0mM
2.0mM
1.0mM

30
5
15

Antioxidant
Antioxidant
Antioxidant

Methimazole

1.0mM

30

FMO

N-Octylamine

2.0mM

5

FMO

Indomethacin
Mercaptosuccinate

1.0mM
0.1mM

15
15

Cyclooxygenase
Peroxidase

PiBx
Metyrapone
Oleandomycin triacetate

1.0mM
1.0mM
0.5mM

15
5
30

NS CYP
NS CYP
CYP3A1/2

Thio-tepa

0.1 mM

5

CYP2B1/2

Isoniazid

1.0mM

5

CYP2E1

DEDTCA

0.1mM

30

Omeprazole

0.01mM

30

CYP2C >
CYP2E1
CYP2C

Sulfaphenazole

0.1mM

30

CYP2C
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Reference
Katsuda et al.
2010
Suzuki et al.
1990
Lau et al. 1987
Lock et al.1993
Harmon et al.
2006, 2005
Rodriquez et al.
1997
Rodriquez et
al.1997
Lau et al. 1987
Racine et al.
2014
Baliga et al.1998
Lock et al. 1993
Racine et al.
2014
Harleton et al.
2004
Racine et al.
2014
Eagling et
al.1998
Racine et al.
2014
Eagling et al.
1998,
Kobayashi,
Urashima,
Shimada, and
Chiba 2003

2.2.4 Glutathione determination
Following treatment with 3,5-DCA (0.5 or 1.0 mM) or vehicle (DMSO) for 60 or 90 min,
IRCC (2.0 ml; 4.2 million cells/ml) were homogenized in 0.5% sulfosalicylic acid (250 µl).
Using a glutathione and NADPH coupled reaction; total glutathione (GSH) was determined as
previously described (Anderson, 1985; Griffith, 1980; Valentovic, Terneus, Harmon, and
Carpenter, 2004). To measure glutathione disulfide (oxidized glutathione; GSSG) 2vinylpyridine derivation was used as described by Griffith (1980). The ratio of oxidized/reduced
GSH was then determined and all results were expressed as percent of control for each set of
experiments.

2.2.5 Protein carbonyl measurement
Protein carbonyl levels were measured after exposure to vehicle (DMSO) or 3,5-DCA
(0.5, 1.0 mM) for 60 or 90 min as previously described by Terneus, Kiningham, Carpenter,
Sullivan, and Valentovic, (2007). Briefly, a sample from treated IRCC (0.5 ml) was
homogenized in 5x volume Krebs buffer, and total protein was determined using a Coomassie
blue spectrophotometric method (Bradford, 1976). Protein OxyBlot kits (Millipore) were utilized
to determine protein carbonyl levels following the manufacturer’s recommended protocol. The
assay utilizes a 2,4-dinitrophenylhydrazine (DNP) specific antibody to detect DNP moiety on
proteins. DNP moieties arise from the reaction of carbonyl side chains formed under oxidative
stress conditions with 2,4-dinitrophenylhydrazine (Terneus et al., 2007).

49

2.2.6 Statistics
Data for LDH release is presented as mean ± S.E.M. with an N ≥ 4 separate isolation
experiments. Data for oxidized/reduced GSH and Oxyblot experiments are presented as mean
percent of control ± S.E.M. with an N ≥ 4 experiments. Data was analyzed by a one-way analysis
of variance followed by a Student-Newman-Keuls Test using GraphPad Prism 6.0. Statistical
significance was determined at P < 0.05.
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2.3 Results
2.3.1 Time and concentration cytotoxicity studies
To determine the nephrotoxic potential of 3,5-DCA in IRCC, concentration response
curves were performed at 60, 90 or 120 min. Cytotoxicity, as determined by increased LDH
release, was seen at 90 and 120 min at a 3,5-DCA concentration of 1.0 mM. Cytotoxicity was
also seen with 0.5 mM 3,5-DCA, but only at the 120 min exposure time (Fig. 8). Based on these
observations, the 3,5-DCA concentration selected for further study was 1.0 mM with an exposure
time of 90 min.

2.3.2 Effects of flavin-containing monooxygenase (FMO), cyclooxygenase, or peroxidase
inhibition
To determine the role of FMOs in 3,5-DCA bioactivation, IRCC were pretreated with the
FMO inhibitors methimazole or N-octylamine. The cyclooxygenase activity of prostaglandin H
synthase was inhibited with indomethacin, while general peroxidase activity was inhibited with
mercaptosuccinate. All pretreatments significantly attenuated 3,5-DCA induced cytotoxicity
(Fig. 9).

2.3.3 Effects of nonselective cytochrome P450 (CYP) inhibition
The role of CYPs in 3,5-DCA induced cytotoxicity was first examined by using the
nonselective CYP inhibitors piperonyl butoxide [PiBx], and metyrapone. Results showed PiBx
and metyrapone both significantly attenuated 3,5-DCA 1.0 mM induced cytotoxicity (Fig. 10).
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Figure 8. 3,5-DCA induced cytotoxicity in isolated renal cortical cells obtained from male
Fischer 344 rats following exposure for 60, 90 and 120 min. Each bar represents the mean ±
S.E.M. for N=4-5 separate isolation experiments. *Significantly different from DMSO control,
P<0.05.
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Figure 9. Effects of FMO, cyclooxygenase, or peroxidase inhibitor pretreatment (PreTX) on 3,5DCA cytotoxicity in isolated renal cortical cells obtained from male Fischer 344 rats after 90
min. Each bar represents the mean ± S.E.M. for N=4-5 separate isolation experiments.
*Significantly different from DMSO control, P<0.05. ∇Significantly different from the 1.0 mM
3,5-DCA value, P<0.05.
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Figure 10. Effects of nonselective cytochrome P450 inhibitor pretreatment (PreTX) on 3,5DCA cytotoxicity in isolated renal cortical cells obtained from male Fischer 344 rats after 90
min. Each bar represents the mean ± S.E.M. for N=4-5 separate isolation experiments.
*Significantly different from DMSO control, P<0.05. ∇Significantly different from the 1.0 mM
3,5-DCA value, P<0.05. PiBx, piperonyl butoxide.
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2.3.4 Effects of isozyme selective CYP inhibition
Based on the results from studies using nonselective CYP inhibitors, further studies were
designed to explore the role of select renal CYP isozymes on 3,5-DCA induced cytotoxicity. To
determine the role of CYP3A, CYP2E1, and CYP2B1/2 isozymes in 3,5-DCA bioactivation,
oleandomycin triacetate, isoniazid, and thio-tepa were used to inhibit CYP3A, CYP2E1, and
CYP2B1/2 isozymes, respectively. Cytotoxicity induced by 3,5-DCA was not significantly
attenuated by any of these pretreatments (data not shown). To determine the role of the CYP2C
family in 3,5-DCA bioactivation, the effects of three CYP2C family inhibitors (omeprazole,
diethyldithiocarbamate (DEDTCA), and sulfaphenazole) on 3,5-DCA cytotoxicity were
examined. Results show that inhibition of the CYP2C family significantly reduced cytotoxicity
(Fig. 11).

2.3.5 Effects of antioxidants on 3,5-DCA cytotoxicity
The effect of pretreating IRCC with antioxidants on 3,5-DCA cytotoxicity was also
examined to explore whether oxidative stress or free radicals played a significant role in 3,5DCA (1.0 mM) induced cytotoxicity. Results showed all five antioxidants (N-acetyl-L-cysteine,
α-tocopherol, glutathione, ascorbate and pyruvate) significantly attenuated 3,5-DCA cytotoxicity
(Fig. 12).
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Figure 11. Effects of CYP2C isozyme selective inhibitor pretreatment (PreTX) on 3,5-DCA
cytotoxicity in isolated renal cortical cells obtained from male Fischer 344 rats after 90 min.
Each bar represents the mean ± S.E.M. for N=4-5 separate isolation experiments. *Significantly
different from DMSO control, P<0.05. ∇Significantly different from the 1.0 mM 3,5-DCA value,
P<0.05.
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Figure 12. Effects of antioxidant pretreatment (PreTX) on 3,5-DCA cytotoxicity in isolated renal
cortical cells obtained from male Fischer 344 rats after 90 min. Each bar represents the mean ±
S.E.M. for N=4-5 separate isolation experiments. *Significantly different from DMSO control,
P<0.05. ∇Significantly different from the 1.0 mM 3,5-DCA value, P<0.05.
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2.3.6 Determination of oxidative stress following exposure to 3,5-DCA
Since antioxidant pretreatment significantly attenuated cytotoxicity, studies were
designed to determine whether oxidative stress following exposure to 3,5-DCA played a role in
cytotoxicity. The presence of oxidative stress was determined by examining the ratio of
oxidized/reduced glutathione (GSH) after exposure to 3,5-DCA (0.5 and 1.0 mM) at 60 and 90
min. These results were then correlated with the appearance of cytotoxicity. Results showed no
significant changes in the ratio of oxidized/reduced GSH at any 3,5-DCA concentration or time
point (Fig. 13), even though some cell death was occurring with the 1.0 mM concentration at the
90 min time point (Fig. 8). However, total GSH and reduced GSH were significantly reduced
following exposure to 3,5-DCA at both concentrations (0.5 mM and 1.0 mM) and times (60 min,
90 min). Oxidized GSH was unchanged at 60 min and was significantly reduced at 90 min with
both concentrations of 3,5-DCA (0.5 mM and 1.0 mM). (Fig. 13)
Protein carbonyl levels were examined as a second marker of oxidative damage to
determine if oxidative stress was a causative factor in cell death. Protein carbonyl levels were
only significantly increased following exposure to 1.0 mM 3,5-DCA after 90 min (Fig. 14), a
time when cell death was evident (Fig. 8). Thus, oxidative damage appears to be secondary to the
causative mechanism of cell death.
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Figure 13. The oxidized/reduced glutathione (GSSG/GSH) ratio following exposure to 3,5-DCA
for 60 (A) or 90 (B) min. Total, oxidized, and reduced GSH following exposure to 3,5-DCA for
60 (C) and 90 (D) min. Each bar represents the percent control ± S.E.M. for N=4-6 separate
isolation experiments. *Significantly different from DMSO control, P<0.05.

59

Figure 14. Oxyblot data following exposure to 3,5-DCA for 60 (A) and 90 (B) min. Each bar
represents the percent control ± S.E.M. for N=4-6 separate isolation experiments. *Significantly
different from DMSO control, P<0.05
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2.4 DISCUSSION
Human exposure to 3,5-DCA can occur in a variety of settings, including during the
manufacture of 3,5-DCA-based pesticides (e.g. iprodione, vinclozolin), dyes, etc. and through
environmental exposure (e.g. application of pesticides, accumulation in waste water). Human
exposure data to 3,5-DCA is extremely limited and blood levels of 3,5-DCA following pesticide
or 3,5-DCA exposure are not reported for humans. Exposure to vinclozolin during manufacture
has been monitored by measuring 3,5-DCA levels in the urine, which can be as high as ~1.4
mg/g creatinine (Zober et al., 1995). However, these levels have not resulted in harmful renal
effects. Thus, nephrotoxicity in humans would most likely occur only through accidental
poisoning, as is seen for aniline (Gosselin, Smith, and Hodge, 1984). A single nephrotoxic dose
of 3,5-DCA in Fischer 344 rats (0.8 mmol/kg, ip) would result in an estimated blood level of
1.25 mM (Lo et al., 1990), a concentration 2.5 times higher than the minimal nephrotoxic
concentration used in this study. However, whether the human kidney would be exposed to these
minimal in vitro nephrotoxic concentrations of 3,5-DCA is unclear at this time.
This study was the first to show the importance of renal biotransformation in 3,5-DCA
induced cytotoxicity. Inhibition of FMO, CYP and peroxidase activity all attenuated cytotoxicity
suggesting that a toxic metabolite is formed following exposure to 3,5-DCA and that multiple
enzyme systems are capable of bioactivating 3,5-DCA and/or its metabolites (Fig. 7).
Antioxidants also offered protection from 3,5-DCA induced cytotoxicity, suggesting that free
radicals are involved in the mechanisms of 3,5-DCA bioactivation and/or cytotoxicity. If the
parent compound alone was responsible for cytotoxicity, inhibition of biotransformation systems
would lead to either no changes in cytotoxicity or an increase in toxicity if one of the pathways
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inhibited was a major detoxifying mechanism. Thus, renal bioactivation of 3,5-DCA contributes
to 3,5-DCA induced cytotoxicity in an IRCC model.
N-Oxidation, N-acetylation, and phenyl ring oxidation are three primary routes of
chloroaniline biotransformation (Ehlhardt and Howbert, 1991; Hong and Rankin, 1998). Based
on these observations and the biotransformation of other chloroanilines in rats, a proposed
biotransformation pathway for 3,5-DCA is shown in Fig. 7. Of these potential biotransformation
pathways, it is known that chloroacetanilides, which arise from N-acetylation catalyzed via Nacetyltransferase enzymes, possess much reduced nephrotoxic potential compared to the parent
chloroanilines (Rankin et al., 1993, 1995). Therefore, it is unlikely that N-acetylation of 3,5DCA to 3,5-dichloroacetanilide (3,5-DCAA) would contribute to the renal cytotoxicity of 3,5DCA. N-Acetyltransferase inhibitors were not evaluated for their ability to reduce 3,5-DCA
nephrotoxicity for this reason. However, studies with 3,5-DCAA are required to confirm its renal
effects and role in 3,5-DCA nephrotoxicity.
Another purposed metabolic pathway that could contribute to 3,5-DCA induced
nephrotoxicity is N-oxidation. N-Oxidation of aromatic amines is known to be catalyzed by
multiple enzymes including CYPs, FMOs, prostaglandin H synthase, and peroxidases
(Bakkenist, Plat, and Wever, 1981; Corbett, Chipko, and Batchelor, 1980; Golly and Hlavica,
1985; McMillan, Leakey, Arlotto, McMillan, and Hinson, 1990; Ochiai, Sakurai, Nomura, Itoh,
and Tanaka, 2006; Sun et al., 2007; Yanni et al., 2010). N-Oxidation of 3,5-DCA would lead to
3,5-dichlorophenylhydroxylamine (3,5-DCPHA) (Fig. 8), whose nephrotoxic potential is yet to
be determined. However, it would not be surprising if 3,5-DCPHA contributed to 3,5-DCA
induced nephrotoxicity because 3,4-dichlorophenylhydroxylamine is a known nephrotoxicant in
vitro using a rat renal cortical slice model (Valentovic, Ball, Stoll, and Rankin, 2001). The results
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of the current study indicate that multiple enzymatic systems that catalyze N-oxidation can
contribute to 3,5-DCA bioactivation, and that N-oxidation is a potential pathway leading to one
or more ultimate, cytotoxic 3,5-DCA metabolites.
Further oxidation of 3,5-DCPHA would result in 3,5-dichloronitrosobenzene, which can
be oxidized to 3,5-dichloronitrobenzene (3,5-DCNB). 3,5-DCNB has been shown to reduce renal
gluconeogenesis at 1.0 mM and increase LDH release at 2.0 mM or higher concentrations after a
90 min exposure in renal cortical slices from Fischer 344 rats (Hong, Anestis, Ball, Valentovic,
and Rankin, 2002). It is unlikely that 3,5-DCNB is the ultimate toxic species following 3,5-DCA
1.0 mM, since a sufficient concentration of 3,5-DCNB to cause LDH release could not be
reached with the 3,5-DCA concentration used in the current study. However, N-hydroxyl and
nitroso compounds have been shown to alter cellular function by covalently binding to cellular
nucleophiles (e.g. GSH, thiols of proteins, etc.) or redox cycling to produce reactive oxygen
species, leading to increased cell death (Eyer and Ascherl, 1987; Kiese and Taeger, 1976;
Stiborová, Frei, Schmeiser, Wiessler, and Anzenbacher, 1992; Umbreit, 2007; Valentovic et al.,
1997). Therefore, any 3,5-dichloronitrosobenzene formed from 3,5-DCPHA could be
contributing to 3,5-DCA cytotoxicity.
Aromatic ring oxidation is another potential biotransformation pathway that could
contribute to 3,5-DCA bioactivation. CYPs can catalyze aromatic ring oxidation, and since CYP
inhibition reduces 3,5-DCA cytotoxicity (Fig. 10), production of phenolic metabolites of 3,5DCA could be an important contributing factor in 3,5-DCA nephrotoxicity. Oxidation of the
aromatic ring can lead to two possible metabolites, 2-amino-4,6-dichlorophenol and 4-amino2,6-dichlorophenol (Fig. 7). While not much is known about 2-amino-4,6-dichlorophenol
nephrotoxicity, 4-amino-2,6-dichlorophenol has been shown to be a potent nephrotoxicant both
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in vivo and in vitro (Hong et al., 1997; Rankin et al., 1994, 2008a; Valentovic et al., 1997).
Interestingly, addition of a chloro group to the 4-position of 3,5-DCA to form 3,4,5trichloroaniline produces a 3,5-DCA derivative without the ability to form significant amounts of
4-amino-2,6-dichlorophenol. However, 3,5-DCA and 3,4,5-trichloroaniline have equal
nephrotoxic potential at 90 min, and 3,4,5-trichloroaniline is more potent as a nephrotoxicant
than 3,5-DCA at 120min in IRCC (Racine et al., 2014). Thus, although 4-amino-2,6dichlorophenol is a nephrotoxicant, it does not appear to be the ultimate nephrotoxic metabolite
arising from 3,5-DCA in vitro. Studies with 2-amino-4,6-dichlorophenol are ongoing to
determine its nephrotoxic potential. Thus, the role of aminophenol metabolites in 3,5-DCA
cytotoxicity remains to be fully determined, but oxidation at the 4-position of 3,5-DCA does not
appear to be a critical bioactivation pathway.
Since the general CYP inhibitors (piperonyl butoxide and metyrapone) were able to
significantly attenuate cytotoxicity, further studies were conducted looking at the role of
selective CYP isozymes which are found in the kidney. Cummings et al. (1999) found CYP2E1,
CYP2C11, CYP2B1/2, and CYP4A2/3 in freshly isolated rat proximal and distal tubular cells.
CYP2E1 expression was higher in distal tubular cells than proximal tubular cells, while
CYP2C11 was higher in proximal tubular cells than distal tubular cells. CYP3A1/2 was not
detected in the proximal tubular cells but was found in total kidney homogenate, which may
indicate why oleandomycin, a CYP3A inhibitor, was not effective in attenuating 3,5-DCA
cytotoxicity. The inability of thio-tepa (CYP2B inhibitor) and isoniazid (CYP2E inhibitor) to
attenuate 3,5-DCA cytotoxicity, suggests that these CYPs are not critical for 3,5-DCA
bioactivation. Of the selective CYP inhibitors we used, only sulfaphenazole, omeprazole, and
diethyldithiocarbamate (DEDTCA) were able to attenuate 3,5-DCA cytotoxicity. These three
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inhibitors all show a preference to inhibit the 2C family of rat isozymes (Eagling et al., 1998;
Kobayashi, Urashima, Shimada, and Chiba, 2003), suggesting that the 2C family may play a role
in the bioactivation of 3,5-DCA. The CYP2C family in rats facilitates N-hydroxylation, as well
as aromatic ring oxidation (Cribb, Spielberg, and Griffin, 1995), which supports one or both of
these pathways as contributing to 3,5-DCA bioactivation.
Both N-hydroxylation and aromatic ring oxidation can lead to an increase in free radicals:
either as metabolites undergoing redox cycling or directly from oxidation during metabolism
(Harmon et al., 2006; Michail, Baghdasarian, Narwaley, Aljuhani, and Siraki 2013), and Nhydroxyl, N-nitroso and aminophenol metabolites can induce cell death via oxidative stress
mechanisms (Harmon et al., 2005; Lock et al., 1993; Umbreit, 2007; Valentovic et al., 1997).
Antioxidant pretreatment proved to be highly effective in attenuating 3,5-DCA cytotoxicity, with
all antioxidants offering protection, suggesting that free radicals may play a role in cytotoxicity.
Oxidative stress was measured by looking at the ratio of GSSG/GSH and increases in protein
carbonyl levels. If oxidative stress played a significant role in the mechanism of cellular death,
an increase in the GSSG/GSH ratio should occur prior to cytotoxicity, as seen with compounds
such as para-aminophenol (Harmon et al., 2005). However, in the case of 3,5-DCA, there was no
significant increase in the GSSG/GSH ratio, and the significant increase in protein carbonyl
levels only occurred after there was an increase in cytotoxicity. These data suggest that oxidative
stress is not responsible for cell death in 3,5-DCA induced nephrotoxicity in vitro, and that the
antioxidants may be offering protection, at least in part, by scavenging one or more radical
metabolites produced during the metabolism of the amino group or an aminophenol metabolite
(e.g. 2-amino-4,6-dichlorophenol) (Fowler, Moore, Foster, and Lock, 1991; Fowler, Foster, and
Lock, 1993).
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Total glutathione levels decreased following 3,5-DCA exposure, even though the
GSSG/GSH ratio didn’t significantly change (Fig. 13). In the absence of oxidative stress, it is
likely that the reduction in total glutathione levels was due to the formation of a reactive 3,5DCA metabolite(s) that was(were) detoxified by reaction with reduced glutathione. Both
addition of GSH and N-acetyl-L-cysteine, which protect cells by being converted to GSH
(Lauterburg, Corcoran, and Mitchell, 1983), to IRCC attenuated 3,5-DCA cytotoxicity. Thus, at
least part of the mechanism of protection from GSH could come from reacting with a reactive
3,5-DCA metabolite. It is also possible that the reduction of the GSSG levels seen at 90 min was
an effort to restore GSH concentrations to a level offering cellular protection. However, further
studies are needed to more clearly determine the role(s) of glutathione in attenuating 3,5-DCA
cytotoxicity.
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2.5 Conclusions
The results of this study determined that, as in rat renal cortical slices, 3,5-DCA is toxic
to IRCC in a time- and concentration-dependent manner. Results also suggest that 3,5-DCA is
potentially bioactivated in the kidney via several biotransformation pathways and that the
CYP2C family is the major contributing renal CYP family for bioactivation. In addition,
oxidative stress does not appear to play a significant role in the causative mechanism of 3,5-DCA
cytotoxicity. While these studies provide insight into the role of biotransformation enzymes in
bioactivating 3,5-DCA to nephrotoxic metabolites, studies are underway to determine the
ultimate toxicant(s) in 3,5-DCA induced nephrotoxicity.
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ABSTRACT
Chloroanilines are widely used in the manufacture of drugs, pesticides and industrial
intermediates. Among the trichloroanilines, 3,4,5-trichloroaniline (TCA) is the most potent
nephrotoxicant in vivo. The purpose of this study was to examine the nephrotoxic potential of
TCA in vitro and to determine if renal biotransformation and/or free radicals contributed to TCA
cytotoxicity using isolated renal cortical cells (IRCC) from male Fischer 344 rats as the animal
model. IRCC (~4 million cells/mL; 3 mL) were incubated with TCA (0, 0.1, 0.25, 0.5 or 1.0
mM) for 60-120 min. In some experiments, IRCC were pretreated with an antioxidant or a
cytochrome P450 (CYP), flavin monooxygenase (FMO), cyclooxygenase or peroxidase inhibitor
prior to incubation with dimethyl sulfoxide (control) or TCA (0.5 mM) for 120 min. At 60 min,
TCA did not induce cytotoxicity, but induced cytotoxicity as early as 90 min with 0.5 mM or
higher TCA and at 120 min with 0.1 mM or higher TCA, as evidenced by increased lactate
dehydrogenase (LDH) release. Pretreatment with the CYP inhibitor piperonyl butoxide, the
cyclooxygenase inhibitor indomethacin or the peroxidase inhibitor mercaptosuccinate attenuated
TCA cytotoxicity, while pretreatment with FMO inhibitors or the CYP inhibitor metyrapone had
no effect on TCA nephrotoxicity. Pretreatment with an antioxidant (α-tocopherol, glutathione,
ascorbate or N-acetyl-L-cysteine) also reduced or completely blocked TCA cytotoxicity. These
results indicate that TCA is directly nephrotoxic to IRCC in a time and concentration dependent
manner. Bioactivation of TCA to toxic metabolites by CYP, cyclooxygenase and/or peroxidase
contributes to the mechanism of TCA nephrotoxicity. Lastly, free radicals play a role in TCA
cytotoxicity, although the exact nature of the origin of these radicals remains to be determined.
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3.1 INTRODUCTION
Chloroanilines are commonly used as chemical intermediates to manufacture dyes,
agricultural chemicals, drugs and industrial compounds. Exposure to chloroanilines can occur in
occupational settings, through the release or formation during the metabolism of compounds in
mammals (Aizawa, 1989; Ehlhardt, 1991; Rickert and Held, 1990) or by the degradation of
pesticides in the environment (Aizawa, 1989; Lee et al., 2008; Santos et al., 1998; Mercadier,
Vega, and Bastide, 1998). In addition, the detection of chloroanilines in human urine or blood
can be used as a biomarker for exposure to chloroaniline-based pesticides (Lindh et al, 2007;
Kutting et al., 2009; Turci, Barisano, Baldducci, Colosio, and Minoia, 2006; Vitelli et al., 2007).
The toxicity associated with exposure to mono- and dichloroanilines includes hematotoxicity
(e.g. methemoglobinemia or anemia) (Chhabra et al., 1990; Guilhermino et al., 1998; Valentovic
et al. 1997, splenotoxicity (Chhabra et al, 1990; Ward, Reznik, and Garner, 1980), hepatotoxicity
(Valentovic et al., 1992, 1995a, 1995b) and nephrotoxicity (Valentovic et al., 1995b; Hong et al.,
2000, Lo et al., 1990). Because of their adverse health effects and release into the environment in
agricultural areas following the breakdown of pesticides, chloroanilines are considered priority
pollutants in environmental risk assessments (Boehncke, Kielhorn, Konnecker, Pohlenz-Michel,
and Mangelsdorfer, 2003; Vangnai et al., 2012).
Trichloroanilines have similar uses as the mono- and dichloroanilines, including use in
drug development (Craciunescu, Furlani, Scarcia, Ghirvu, and Doadrio, 1985; Imai, Takahashi,
Watanabe, Nakazawa, and Yamanaka, 1991; Limban, Marutescu, and Chifiriuc, 2011), dye
manufacturing (Peters and Yang, 1996) and production of agricultural agents (Aggarwal, Kumar,
Dureja, and Rawat, 2009). While the potential adverse health effects of mono- and
dichloroanilines have been studied in some detail, little information is available about the
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toxicity induced by trichloroanilines, including the nephrotoxic potential of trichloroanilines or
their mechanisms of inducing nephrotoxicity. Lo, Brown, and Rankin (1991) examined the in
vivo and in vitro effects of four trichloroanilines (2,3,4-, 2,4,5-, 2,4,6- and 3,4,5-trichloroaniline)
on the renal function of male Fischer 344 rats. They noted that of the four trichloroanilines
tested, 3,4,5-trichloroaniline (TCA) had the greatest nephrotoxic potential in vivo as evidenced
by oliguria, increased kidney weight, elevated blood urea nitrogen concentration and altered
renal organic ion accumulation. In vitro, TCA was also the most potent nephrotoxicant of the
four trichloroanilines tested, decreasing tetraethylammonium accumulation by renal cortical
slices at 1.0 µM concentration (Lo et al., 1991).
Although it is known that metabolites of mono- and dichloroanilines are toxic to the
kidney in vivo and in vitro (Hong et al., 1996; Hong et al., 1997; Rankin, Hong, Anestis, Ball,
and Valentovic, 2008a; Valentovic et al., 2001), no studies have examined the role of
biotransformation in trichloroaniline nephrotoxicity. It is also unknown if the kidney bioactivates
parent chloroanilines to nephrotoxic metabolites, or if the parent chloroaniline is toxic to the
kidney without bioactivation. The purpose of this study was to begin to examine the role of
biotransformation of a trichloroaniline in the nephrotoxicity it produces in vitro as well as
determine if free radicals contributed to the cytotoxicity. TCA was selected for study because it
is the most potent trichloroaniline nephrotoxicant in vivo and in vitro. The Fischer 344 rat was
selected as the animal model because our previous studies with chloroaniline-induced
nephrotoxicity have been conducted in this animal model. The inhibitor pretreatments,
concentrations and times selected for study were based on previous reports (Lock et al., 1993;
Baliga et al., 1998; Rodriguez and Acosta, 1997; Valentovic et al., 1999; O’Brien and Siraki,
2005; Lau and Monks, 1987; Katsuda et al., 2010 Suzuki and Sudo, 1990).
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3.2 RESULTS
3.2.1 Time and concentration cytotoxicity studies
To obtain information concerning the nephrotoxic potential of TCA in isolated renal
cortical cells (IRCC), a concentration response study was performed at 60, 90 and 120 min.
IRCC exposed to TCA at concentrations up to 1.0 mM for 60 min did not exhibit any
cytotoxicity (data not shown). A 90 min exposure to TCA at a concentration of 0.5 mM or higher
induced cytotoxicity (increased LDH release), while at 120 min of exposure, cytotoxicity was
evident at a concentration of 0.1 mM TCA or higher (Figure 15). Based on these findings, a
concentration of 0.5 mM and an exposure time of 120 min were selected for use in the
antioxidant and inhibitor pretreatment studies.

3.2.2 Effects of antioxidants on TCA cytotoxicity
The effects of pretreating IRCC with an antioxidant on TCA cytotoxicity was examined
next (Figure 16). All four antioxidants (α-tocopherol, ascorbate, glutathione and N-acetyl-Lcysteine) provided at least some degree of attenuation of TCA cytotoxicity. Glutathione and
ascorbate were most effective and α-tocopherol was the least effective at attenuating TCA
cytotoxicity.
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Figure 15. Cytotoxic effects of TCA at 90 min (Panel A) and 120 min (Panel B) in IRCC. An
asterisk indicates significantly different from the DMSO control group value, P<0.05.
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Figure 16. Effect of antioxidant pretreatment on TCA cytotoxicity at 120 min. An asterisk
indicates significantly different from the DMSO control group value, P<0.05. A diamond
indicates significantly different from the 0.5 mM TCA alone value, P<0.05
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3.2.3 Effects of cytochrome P450 (CYP) and flavin monooxygenase (FMO) inhibition
The effects of inhibiting CYP and FMO activity on TCA cytotoxicity were examined
using nonselective CYP (piperonyl butoxide [PiBX] and metyrapone) and FMO (methimazole
and N-octylamine) inhibitors. Inhibition of CYPs with PiBX, but not metyrapone, attenuated
TCA cytotoxicity (Figure 17). Inhibition of FMOs with either methimazole or N-octylamine had
no effect on TCA induced cell death (Figure 17).

3.2.4 Effects of cyclooxygenase and peroxidase inhibition
The effect of inhibiting the cyclooxygenase activity of prostaglandin H synthase on TCA
cytotoxicity was determined using indomethacin pretreatment, while mercaptosuccinate was
used as a general peroxidase inhibitor. Both indomethacin pretreatment and mercaptosuccinate
pretreatment reduced TCA cytotoxicity (Figure 18).
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Figure 17. Effect of FMO or CYP inhibition on TCA cytotoxicity at 120 min. An asterisk
indicates significantly different from the DMSO control group value, P<0.05. A diamond
indicates significantly different from the 0.5 mM TCA alone value, P<0.05.
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Figure 18. Effect of cyclooxygenase or peroxidase inhibition on TCA cytotoxicity at 120 min.
An asterisk indicates significantly different from the DMSO control group value, P<0.05. A
diamond indicates significantly different from the 0.5 mM TCA alone value, P<0.05.
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3.3 DISCUSSION
This study is the first report to demonstrate the direct cytotoxic effects of TCA on the kidney.
In a previous study, the in vitro effects of TCA on organic ion transport by renal cortical slices
from male Fischer 344 rats suggested that TCA could affect renal function, decreasing organic
cation accumulation at concentrations as low as 1.0 µM, and affecting both organic anion and
cation accumulation at 1.0 mM (Lo et al., 1991). However, TCA is a weakly basic compound.
Thus, the possibility existed that the effects seen at µM concentrations of TCA in the work by Lo
et al. (1991) were more related to interactions at the organic cation transporter level than
cytotoxicity, and that cytotoxicity was not observed until TCA concentrations reached mM
levels. Results from the present study clearly demonstrate that TCA can induce cytotoxicity at
µM concentrations, as evidenced by increased LDH release at concentrations of TCA as low as
100 µM at 120 min, and that TCA induces cytotoxicity in a time and concentration dependent
manner.
The ability of the various inhibitors used in this study to attenuate TCA cytotoxicity suggests
that metabolites of TCA contribute to TCA nephrotoxicity in vitro. The biotransformation of
TCA has only been reported in fish (De Wolf, Seinen, and Hermens, 1993). However, based on
studies of the metabolism of other chloroanilines in rats (Hong et al., 1998; Ehlhardt and
Howbert, 1991; McMillan, Leakey, Arolotto, McMIllan, and Hinson, 1990; McMillan, Jensen,
and Jollow, 1998), a potential biotransformation pathway for TCA can be proposed which
includes acetylation, N-oxidation and aromatic ring oxidation (Figure 19).
N-Acetylation is catalyzed by cytosolic N-acetyltransferase enzymes, and it is unlikely that
any of the pretreatments used in this study would alter this biotransformation reaction. In
addition, acetylation of chloroanilines produces chloroacetanilides, which have greatly reduced
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nephrotoxic potential in vivo (Rankin et al., 1993). Thus, it is unlikely that acetylation would be
a mechanism for bioactivation of 3,4,5-trichloroaniline.
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Figure 19. Potential metabolic pathways for TCA. NAT = N-acetyltransferase, CYP =
cytochrome P450, FMO = flavin-containing monooxygenase
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Oxidation of the aromatic ring to produce 2-amino-4,5,6-trichlorophenol would be a potential
bioactivation mechanism for TCA, as many aminophenols are known nephrotoxicants (Hong et
al., 1996, 1997; Lock et al., 1993; Rankin et al., 1994, 2008a). Production of an aminophenol
metabolite of TCA would be catalyzed by CYPs, as McMillan et al. (1990, 1998) found that
aromatic ring oxidation of 3,4-dichloroaniline was catalyzed by CYPs. Whether 2-amino-4,5,6trichlorophenol is produced in the kidney from TCA and contributes to TCA nephrotoxicity
remains to be determined. However, a structurally-related metabolite, 2-amino-4,5dichlorophenol, is directly toxic to renal cortical slices from male Fischer 344 rats (Valentovic et
al., 2002). Attenuation of TCA cytotoxicity by the CYP inhibitor PiBX suggests that aromatic
ring oxidation may be a potential route of TCA bioactivation. Nonetheless, the inability of
another general CYP inhibitor, metyrapone, to reduce TCA cytotoxicity indicates that further
study is needed to clarify which CYPs may contribute to TCA bioactivation to toxic metabolites
and the role of 2-amino-4,5,6-trichlorophenol in TCA nephrotoxicity. The use of additional,
more specific CYP inhibitors will help define the role and nature of the CYPs contributing to the
production of toxic metabolites in TCA metabolism.
N-Oxidation can be catalyzed by several enzyme systems, including CYPs, FMOs,
prostaglandin H synthase and peroxidases (McMillan et al., 1998; Ochiai et al., 2006; Yanni et
al., 2010; Golly and Hlavica, 1985; Corbett et al., 1980, Bakkenist et al., 1981). The N-oxidation
pathway has the potential to lead to metabolites that could damage cells via multiple pathways
(Figure 19). Metabolites, such as the N-hydroxyl and nitroso metabolites can redox cycle to
produce reactive oxygen species and other free radicals which can damage membranes and lead
to oxidative stress (Valentovic et al., 1997; Umbreit, 2007). In addition, N-hydroxyl and nitroso
metabolites have the ability to be further activated to form covalent bonds with cellular
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nucleophiles to alter cellular function and led to cell death (Kiese and Taegar, 1976; Eyer and
Ascherl et al., 1987; Stiborová, Frei, Schmeiser, Wiessler, and Anzenbacher, 1992). The ability
of PiBX, indomethacin and mercaptosuccinate, but not methimazole or N-octylamine, to
attenuate TCA cytotoxicity suggests that multiple enzyme systems may be involved in
bioactivating TCA to toxic metabolites via the N-oxidation pathway, but renal FMOs do not
appear to contribute to this bioactivation mechanism. That N-oxidation would contribute to TCA
cytotoxicity is not completely surprising, as 3,4-dichlorophenylhydroxylamine, the N-oxidation
metabolite of 3,4-dichloroaniline, is a known nephrotoxicant in vitro to rat renal cortical slices
(Valentovic et al., 2001).
The ability of the four antioxidants to attenuate TCA cytotoxicity suggests that free radicals
contribute to the mechanism of renal injury induced by TCA. These free radicals may be
produced during the oxidation of an aromatic amine or its metabolites (Loew and Goldblum,
1985), or as a consequence of redox cycling of aminophenol or
phenylhydroxylamine/nitrosobenzene metabolites to produce reactive oxygen species and
oxidative stress (Umbreit, 2007; Harmon et al., 2006). Further work is required to determine if
either or both of these potential pathways explains the mechanism of protection by antioxidants
on TCA cytotoxicity. Preliminary work with another chloroaniline, 3,5-dichloroaniline, suggests
that oxidative stress may not contribute to the in vitro nephrotoxicity induced by 3,5dichloroaniline (Racine et al., 2016), but studies with TCA have not been conducted to determine
how free radicals contribute to TCA nephrotoxicity in vitro and are necessary to define the exact
role of free radicals in TCA nephrotoxicity.
It is interesting to note that α-tocopherol, a lipophilic compound, was the weakest of the four
antioxidants in attenuating TCA nephrotoxicity. It would be expected that α-tocopherol would

82

enter IRCC via a passive diffusion mechanism, while renal transporters can promote the
accumulation of ascorbate, glutathione and N-acetyl-L-cysteine (Lee et al., 2006; Lash et al.,
2011; Koh, Simmons-Willis, Pritchard, Grassel, and Ballatori, 2002). Glutathione can also be
accumulated in proximal tubular cells via processing at the luminal membrane and re-synthesis
from the accumulated amino acids. Thus, higher intracellular concentrations of ascorbate,
glutathione and N-acetyl-L-cysteine may be achieved in IRCC as compared to α-tocopherol. In
addition, while all of the antioxidants have the ability to scavenge and detoxify a variety of free
radicals and reactive oxygen and nitrogen species to varying degrees (Machlin and Bendich,
1987), α-tocopherol associates with membranes and appears to have a primary role in preventing
lipid peroxidation which can lead to cell death. Thus, if TCA does not induce oxidative stress
and lipid peroxidation as its primary mechanism for inducing nephrotoxicity, α-tocopherol would
be expected to be less effective than the other antioxidants used in this study. However,
additional studies are needed to clarify the role of oxidative stress and lipid peroxidation in TCA
nephrotoxicity.
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3.4 EXPERIMENTAL SECTION
3.4.1 Experimental animals
Male Fischer 344 rats (220-280g) from Hilltop Lab Animals (Scottdale PA) were used
for all experiments. All animals were kept under controlled environments consisting of regulated
light cycle (on 12 hours, off 12 hours), temperature (21-23oC), and humidity (40-55%) and were
housed in standard plastic cages (two rats per cage). Animals were allowed to acclimate for at
least one week before being used in experiments. Purina Rat Chow and water were available ad
libitum. The Marshall University Institutional Care and Use Committee approved all animal use.
Studies were performed at an AAALAC (Association for the Assessment and Accreditation of
Laboratory Animal Care International) accredited facility and all animal care was in accordance
with the American Association of Laboratory Animal Sciences (AALAS) Policy on the Humane
Care and Use of Laboratory Animals (http://www.aalas.org).

3.4.2 Chemicals
All chemicals used were of the highest purity available and were purchased from Sigma
Aldrich (St. Louis, MO).

3.4.3 Isolated Renal Cortical Cell (IRCC) preparation and treatment
Naïve rats were anesthetized with pentobarbital (75 mg/kg, i.p.) and isolated renal
cortical cells (IRCC) were obtained using the collagenase perfusion method of Jones et al.
(1979). Cell viability was initially determined by trypan blue (2% w/v) exclusion and lactate
dehydrogenase (LDH) release. IRCC were counted and re-suspended in Krebs-Henseleit buffer,
pH 7.4, containing 25 mM Hepes and 2% (w/v) bovine serum albumin at a concentration of ~4.0
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million cells/mL. IRCC (3 mL) were added to a 25 mL polycarbonate Erlenmeyer flask for a five
min pre-incubation period in a shaking water bath incubator (37˚C, 60 cycles/min) under a 95%
oxygen/5% carbon dioxide atmosphere. IRCC were then exposed to various concentrations of
TCA (0, 0.1, 0.25, 0.5, or 1.0 mM) for 60, 90 or 120 minutes. After the incubation period, flasks
were removed and placed on ice. Samples (0.5 mL) were taken for lactate dehydrogenase (LDH)
release assays. Briefly, samples were centrifuged (3000xg, 3 min), the supernatant was decanted
and saved, and the pellet was disrupted with 1 mL of 10% Triton X-100 solution to release
cellular LDH activity. LDH activity was then determined in each fraction (supernatant and
pellet) as previously described using a kinetic assay based on the amount of NADH produced
from NAD (Rankin et al., 2008b). LDH released was expressed as % of total (supernatant plus
pellet).
In separate experiments, IRCC were pretreated with either an antioxidant or an enzyme
system inhibitor before exposure to 0.5 mM TCA for an additional 120 minutes as described
above. The concentrations and pretreatment times for all of the pretreatments are shown in Table
5.
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Table 5. List of pretreatments and mechanisms/targeted enzyme systems.
Pretreatment

Concentration (mM)

N-Acetyl-L-cysteine
α-Tocopherol
Glutathione
Ascorbate
Methimazole
N-Octylamine
Indomethacin

2.0
1.0
1.0
2.0
1.0
2.0
1.0

Pretreatment Time
(Min)
30
5
30
5
30
5
15

Piperonyl Butoxide

1.0

15

Metyrapone

1.0

5

Mercaptosuccinate

0.1

15
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Mechanism of
Action
Antioxidant
Antioxidant
Antioxidant
Antioxidant
FMO Inhibitor
FMO Inhibitor
Cyclooxygenase
Inhibitor
Non-specific CYP
Inhibitor
Non-specific CYP
Inhibitor
Peroxidase Inhibitor

3.4.4 Statistics
Data are presented as mean ± S.E.M. with an N ≥ 4. Data were analyzed by one-way
analysis of variance followed by a Student-Newman-Keuls Test. Statistical significance was
determined at P < 0.05, α=0.5.
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3.5 CONCLUSIONS
The results of this study demonstrate that TCA is toxic to the kidney in a time and
concentration dependent manner. Toxicity was evident as early as 90 min with 0.5 mM TCA and
with 0.1 mM TCA at 120 min. Since several of the enzyme inhibitor pretreatments attenuated
3,4,5-cytotoxicity, metabolites appear to contribute to the renal toxicity induced by TCA.
Bioactivation of TCA to nephrotoxic metabolites via renal CYPs, cyclooxygenase and/or
peroxidases, but not FMOs, are potential mechanisms of TCA nephrotoxicity. Free radicals also
play a role in TCA nephrotoxicity, as evidenced by the inhibition of TCA cytotoxicity by
antioxidants. However, whether the free radicals are intermediates in TCA biotransformation or
reactive oxygen species produced during TCA metabolism remains to be determined.
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ABSTRACT
Previous studies have suggested that 3,5-dichloroaniline (3,5-DCA; 1.0 mM; 90 min exposure),
an intermediate used in the production of agricultural and industrial products, may undergo renal
bioactivation resulting in toxic metabolite(s) in isolated renal cortical cells (IRCC) obtained from
male Fischer 344 rats. Studies using renal cortical slices have also shown that 4-amino-2,6dichlorophenol (4A26DCP), a putative metabolite of 3,5-DCA, is a potent nephrotoxicant,
however, the metabolism of 3,5-DCA and the nephrotoxic potential of putative metabolites has
not yet been explored in IRCC. The current study was designed to explore the nephrotoxic
potential of five putative 3,5-DCA metabolites (3,5-dichloroacetanilide, 3,5-DCAA; 3,5dichlorophenylhydroxylamine, 3,5-DCPHA; 4-amino-2,6-dichlorophenol, 4A26DCP; 2-amino4,6-dichlorophenol, 2A46DCP; 3,5-dichloronitrobenzene, 3,5-DCNB) and to determine the
metabolism of 3,5-DCA by IRCC. IRCC were exposed to various concentrations of 3,5-DCAA
(0.5,1.0, or 1.5 mM), 3,5-DCNB (0.5, 1.0, or 1.5 mM), 3,5-DCPHA (0.25, 0.5, or 1.0 mM),
2A46DCP (0.5, 1.0, or 1.5 mM), or 4A26DCP (0.1, 0.25, or 0.5 mM). Of these metabolites, only
3,5-DCAA proved noncytotoxic at the concentrations tested. In contrast, the other four
metabolites proved to be nephrotoxic at concentrations and/or exposure times equal to or lower
than 3,5-DCA (1.0 mM; 90 min). To determine the metabolic profile of 3,5-DCA in IRCC, IRCC
were exposed to 0.5 mM or 1.0 mM 3,5-DCA for 45 or 90 minutes. HPLC analysis demonstrated
minimal metabolism occurs in IRCC following exposure to 3,5-DCA. In fact, only two minor
metabolites (3,5-DCNB and 3,5-DCAA) and 3,5-DCA were detected. Since 3,5-DCNB arises
from N-oxidation of 3,5-DCA, and previous studies showed that DEDTCA, a CYP2C selective
inhibitor, can significantly attenuate 3,5-DCA induced toxicity, additional studies were
conducted to determine the metabolic profile of 3,5-DCA in IRCC following pretreatment with
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DEDTCA. Results showed a decrease in the production of 3,5-DCNB following DEDTCA
pretreatment. This result suggests that N-oxidation may play a role in 3,5-DCA induced
nephrotoxicity, while further studies are required to determine the ultimate toxicant(s) species, as
well as the mechanism of cell death.
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ABBREVIATIONS:
3,5-DCA, 3,5-dichloroaniline; 3,5-DCAA, 3,5-dichloroacetanilide;l 2A46DCP, 2-amino-4,6dichlorophenol; 3,5-DCPHA, 3,5-dichlorophenylhydroxylamine; IRCC, isolated renal cortical
cells; LDH, lactate dehydrogenase; DMSO, dimethyl sulfoxide; FMO, flavin-containing
monooxygenase; CYP, cytochrome P450; DEDTCA, diethyldithiocarbamate; 3,5-DCNB, 3,5dichloronitrobenzene, 4-amino-2,6-dichlorophenol; 4A26DCP
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5.1 INTRODUCTION
Chlorinated aniline-induced hematotoxicity (Chhabra et al., 1990; Guilhermino et al.,
1998; Pauluhn, 2004; Valentovic et al., 1997), splenotoxicity (Chhabra et al., 1990; Khan et al.,
1999; Ma et al., 2008, 2013), hepatotoxicity (Valentovic et al., 1995a, 1995b, 1992), and
nephrotoxicity (Hong et al., 2000; Lo et al., 1990; Racine et al., 2014; Valentovic et al., 1995a)
has been well established. These studies have shown that of the chlorinated anilines, 3,5dichloroaniline (3,5-DCA) is the most potent as a nephrotoxicant. In vivo exposure to 3,5dichloroaniline, in rats, results in oliguria, elevated blood urea nitrogen (BUN) concentration,
decreased organic ion transport in proximal tubule cells, decreased kidney weight, increased
proteinuria, and hematuria (Rankin et al., 1986; Lo et al., 1990; Valentovic et al., 1995a). The
greatest morphological changes occur in the proximal tubular cells, but the distal tubular and
collecting ducts were also affected to a lesser degree (Lo et al., 1990). Further studies using
isolated renal cortical cells (IRCC) from male Fischer 344 rats demonstrated that 1.0 mM 3,5DCA exposure for 90 min leads to increased cytotoxicity as evidenced by increased lactate
dehydrogenase (LDH) release, a marker of cytotoxicity. These studies also demonstrated that
3,5-DCA nephrotoxicity can be attenuated by inhibiting multiple enzyme systems, suggesting
that biotransformation, especially N-oxidation, plays a role in 3,5-DCA-induced nephrotoxicity
in vitro (Racine et al., 2016). However, the ultimate toxic metabolite(s) is not currently known.
Based on studies with aniline and its mono-chlorinated derivatives, N-oxidation, Nacetylation, and phenyl ring oxidation are all potential biotransformation pathways of 3,5-DCA
(Figure 20; Ehlhardt and Howbert, 1991; Hong and Rankin, 1998; Racine et al., 2014; 2016). In
the case of 3,5-DCA, it has been demonstrated that one putative metabolite, resulting from
phenyl ring oxidation of 3,5-DCA at the para-position, 4-amino-2,6-dichlorophenol (4A26DCP)
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is a potent nephrotoxicant in Fischer 344 rats both in vivo and in vitro using a renal slice model
(Hong et al., 1996; Rankin et al., 2008a). However, there are few studies that have explored the
metabolism of 3,5-DCA in mammals, and none of these were conducted in the isolated renal
cortical cell (IRCC) model. Marbouh et al. (2002) explored the urinary metabolites of 3,4- and
3,5-DCA following both percutaneous and oral administration. In this study, male SpragueDawley rats were exposed to 12 mg of 3,5-DCA in methanol applied topically or via oral gavage.
Urine was collected for 24 hours post exposure. HPLC analysis of the urine found 0.04% of the
dose was 3,5-dichloroacetanilide (3,5-DCAA), less than 0.01% was 2-amino-4,6-dichlorophenol
(2A46DCP), and 0.57% of the dose was recovered as 3,5-DCA. Following acid hydrolysis to
determine conjugated metabolites, 4.79% of the dose was 3,5-DCA and 0.02% of the dose was
2A46DCP, suggesting that conjugated metabolites of 3,5-DCA and 2A46DCP were formed after
exposure to 3,5-DCA. 3,5-DCAA was not detected following acid hydrolysis. Deacetylation
following acid hydrolysis has been shown in previous studies (Kao et al., 1978).
The current study was designed to determine the metabolism of 3,5-DCA in IRCC from
male Fischer 344 rats as well as to explore the nephrotoxic potential of five putative 3,5-DCA
metabolites. Based on previous studies with aniline and mono-chlorinated derivatives, it was
hypothesized that only those putative metabolites arising from N-oxidation (3,5dichlorophenylhydroxylamine, 3,5-DCPHA; 3,5-dichloronitrosobenzene, 3,5-DCNSB; 3,5dichloronitrobezene, 3,5-DCNB) and/or phenyl ring oxidation (4-amino-2,6-dichlorophenol,
4A26DCP; 2-amino-4,6-dichlorophenol, 2A46DCP) would be cytotoxic while the acetylated
product, 3,5-DCAA, would show a reduced nephrotoxic potential when compared to 3,5-DCA.
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Figure 20. Proposed renal biotransformation pathway of 3,5-DCA. 3,5-DCA ,3,5dichloroaniline, 3,5-DCAA, 3,5-dichloracetanilide; 3,5-DCPHA, 3,5dichlorophenylhydroxylamine; 3,5-DCNSB, 3,5-dichloronitrosobenzene; 3,5-DCNB, 3,5dichloronitrobenzene; 4A26DCP, 4-amino-2,6-dichlorophenol; 2A46DCP, 2-amino-4,6dichlorophenol.
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5.2 MATERIALS AND METHODS

5.2.1 Animals
Male Fischer 344 rats (200-250g) were obtained from Hilltop Lab Animals, Inc.
(Scottsdale, PA). Animals were housed 2 rats/cage with food and water available ad libitum,
while temperature (21-23 C), humidity (40-55%), and light (12 h on/12 h off) are controlled.
Prior to use, all animals were allowed one week to acclimate. All animals use was approved by
the Marshall University Institutional Animal Care and Use Committee, and animal use
experiments were conducted in accordance with the Guide for the Care and Use of Laboratory
Animals, adopted by the National Institute of Health.

5.2.2 Chemicals
All chemicals were purchased at the highest purity available from either Fischer
Scientific (Pittsburgh, PA) or Sigma Aldrich (St. Louis, MO), except for 3,5-DCPHA,
2A46DCP, 3,5-DCAA, which were synthesized in our laboratory. 3,5-DCPHA was synthesized
using previously described methods (Rondestvedt and Johnson, 1977). Briefly, 3,5-DCNB was
reduced with hydrazine-palladium on carbon, prior to recrystallization using benzene-petroleum
ether. 2A46DCP was synthesized and purified using a modified method previously described by
Christiansen (1923) and Newell, Argus, and Ray. (1960). 3,5-DCAA was synthesized and
purified using a modified method described by Searle and Cupery (1954). Purity was determined
using melting point, thin-layer chromatography, infrared spectrophotometry, and nuclear
magnetic resonance spectroscopy techniques.
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5.2.3 Preparation and treatment of Isolated Renal Cortical Cells (IRCC)
Renal cortical cells were obtained from untreated male Fischer 344 rats anesthetized with
pentobarbital (75 mg/kg, ip) via the Jones et al. (1979) collagenase perfusion method. Initial cell
viability was determined by lactate dehydrogenase (LDH) release and trypan blue (2% w/v)
exclusion. Prior to incubation, IRCC were counted and resuspended in Krebs-Henseleit (pH
7.37; 25 mM Hepes; 2% w/v bovine serum albumin) buffer at a concentration of ~4.2 million
cells/ml. IRCC (3 ml) were pre-incubated in 25 ml polycarbonate Erlenymyer flasks for five min
at 37°C under 95:5 oxygen/carbon dioxide. Following pre-incubation, cells were exposed to
various concentrations of 3,5-dichloronitrobenzene (3,5-DCNB; 0.5, 1.0, or 1.5 mM), 3,5dichloroacetanilide (3,5-DCAA; 0.5, 1.0, or 1.5 mM), 3,5-dichlorophenylhydroxylamine (3,5DCPHA; 0.25, 0.5, or 1.0 mM), 2-amino-4,6-dichlorophenol (2A46DCP; 0.5, 1.0, or 1.5 mM), 4amino-2,6-dichlorophenol (4A26DCP; 0.1, 0.25, or 0.5 mM) or vehicle (30 µL DMSO) for 60 or
90 min. At the conclusion of the allotted incubation period, samples (0.5 ml) were taken for LDH
release assay, as previously described (Rankin et al., 2008a, Racine et al., 2014).

5.2.4 HPLC determination of 3,5-DCA metabolism
To determine the metabolism of 3,5-DCA, IRCC were exposed to 3,5-DCA (0.5 mM or
1.0 mM) for 90 min. Following incubation, a 1.0 mL aliquot was taken for HPLC analysis.
HPLC samples were centrifuged, 0.9 mL of supernatant was collected and labeled as media. The
cell pellet was then rinsed with 1.0 mL Krebs Heinselt (KH) buffer without BSA and 0.9 mL of
the rinse was collected, and the pellet was saved for analysis. Methanol (MeOH; 0.9 mL) was
added to the rinse and media fractions, while 1.0 mL of MeOH was added to the cell lysate.
Following the addition of MeOH to precipitate protein, all samples were sonicated for 30 sec
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prior to being centrifuged @3000xg for 10 min @4°C, supernatant was filtered through 0.45
micron syringe filters, and stored at -20°C until analysis.
Separate experiments were conducted to determine whether conjugated metabolites of
3,5-DCA are formed in IRCC. In these experiments, IRCC were incubated with either DMSO
(30 µL) or 3,5-DCA (1.0 mM) for 45 or 90 minutes. Following the incubation, three aliquots (0.9
mL each) were taken for each treated group. The first was prepared as discussed above. The
other two underwent the same processing, until the addition of MeOH. Instead of adding MeOH
each fraction (media, cells, and rinse) was treated with either β-glucuronidase (6500 units/mL;
final concentration) or arylsulfatase (200 units/mL: final concentration) containing
saccharolactone (20mM: final concentration) in 0.1 M acetate buffer (pH 5.0) for 18 h at 37°C.
Saccharolactone inhibited any β-glucuronidase activity which may be present in the arylsulfatase
preparation (Kao et al., 1978). The β-glucuronidase and arylsulfatase incubations were
terminated by the addition of cold MeOH (2.4 mL). Once the MeOH was added, all samples
were sonicated for 30 seconds prior to being centrifuged @3000xg for 10 min @4°C,
supernatant was filtered through 0.45 micron syringe filters, and stored in -20°C, until analyzed
using HPLC. 3,5-DCA stability was determined by incubating 3,5-DCA in KH buffer (as
previously described) without BSA only for 18 h at 37°C before a sample was taken as described
above and compared to a non-incubated 3,5-DCA sample.
Finally, since previous studies suggested that the diethyldithiocarbamic acid (DEDTCA),
a CYP2C selective inhibitor, was able to attenuate 3,5-DCA induced cytotoxicity to control
levels (Racine et al., 2016), experiments were conducted to determine the effect of DEDTCA on
3,5-DCA metabolism. In this experiment cells were pretreated with DEDTCA (0.1 mM; 30 min)
before being exposed to 3,5-DCA (1.0 mM; 90 min), as previously described (Racine et al.,
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2016). Following incubation, samples were collected and prepared for HPLC analysis as
described above.

5.2.5 HPLC Parameters
All HPLC samples (75 µL) were analyzed on a Waters Alliance e2695 HPLC system,
utilizing a Waters 2489 variable UV/Vis detector at 254 nM. Chromatograms were collected and
integrated using Empower 3 software from Waters. A Waters X Select HSS T3 C18 column
(3.5µm; 4.6 x 150 mm) fitted with a Waters XSelect HSS T3 VanGuard Cartridge (3.5 µm; 3.9 x
5 mm) was used for separation of compounds. The mobile phase consisted of 50:50 MeOH:H2O
with a flow rate of 0.75 mL/min. Standard curves, limits of detection, and extraction coefficients
were determined for 3,5-DCA and putative metabolites. Extraction coefficients were determined
by comparing the integration of a 1.0 mM 3,5-DCA or metabolite sample that had undergone
sample processing (i.e., the addition of MeOH and centrifugation) to that of a 1.0 mM 3,5-DCA
or metabolite sample unprocessed.

5.2.6 Statistics
Data is presented as mean ± S.E.M. with an N ≥ 4 separate isolation experiments and was
analyzed by one-way analysis of variance followed by Student Newman-Keuls Test using
GraphPad Prism 7.0. Significance was determined at p< 0.05.
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5.3 RESULTS

5.3.1 Nephrotoxic potential of putative 3,5-DCA metabolites
To determine the nephrotoxic potential of the putative metabolites, concentration and
time course studies were conducted for each of the metabolites listed above. Exposure to 3,5dichloroacetanilide (3,5-DCAA) did not significantly increase LDH release (Figure 21A), a
marker of cytotoxicity, at any time or concentration tested. In contrast, exposure to 2-amino-4,6dichlorophenol (2A46DCP) resulted in significant increases in LDH release at all concentrations
after 90 min, but no significant increases at 60 min. (Figure 21B). 3,5-Dichloronitrobenzene (3,5DCNB; Figure 22) and 3,5-dichlorophenylhydroxylamine (3,5-DCPHA; Figure 23), 4-amino2,6-dichlorophenol (4A26DCP; Figure 24) exposure resulted in a time and concentration
dependent increase in LDH release. Significant LDH release was seen at all concentrations (0.5,
1.0, and 1.5 mM) after 90 minutes for 3,5-DCNB and at 1.0 mM or greater after 60 min. 3,5DCPHA induced a significant increase in LDH release at 0.5 mM or greater after 60 min and at
all concentrations (0.25, 0.5, and 1.0 mM) examined at 90 min. 4A26DCP significantly increased
LDH release at a concentration of 0.5 mM after 60 min and at concentrations greater than or
equal to 0.25 mM after 90 min.
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Figure 21. 3,5-Dichloroacetanilide and 2-amino-4,6-dichlorophenol induced cytoxicity in IRCC
from male Fischer 344 rats. A) 3,5-DCAA induced LDH release in isolated renal cortical cells
obtained from male Fischer 344 rats following exposure for 60 or 90 min. B) 2A46DCP induced
cytotoxicity in isolated renal cortical cells obtained from male Fischer 344 rats following
exposure for 90 min. Each bar represents the mean ± S.E.M. for N=4-5 separate isolation
experiments. *Significantly different from DMSO control, P<0.05.
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Figure 22. 3,5-Dichloronitrobenzene induced cytotoxicity in IRCC from male Fischer 344 rats.
Cells were exposed for 30, 60, or 90 min. Each bar represents the mean ± S.E.M. for N=4-5
separate isolation experiments. *Significantly different from DMSO control, P<0.05.
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Figure 23. 3,5-Dichlorophenylhydroxylamine induced cytotoxicity in IRCC from male Fischer
344 rats. Cells were exposed for 60 or 90 min. Each bar represents the mean ± S.E.M. for N=4-5
separate isolation experiments. *Significantly different from DMSO control, P<0.05.
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Figure 24. 4-Amino-2,6-dichlorophenol induced cytotoxicity in IRCC from male Fischer 344
rats. Cells were exposed for 60 or 90 min. Each bar represents the mean ± S.E.M. for N=4-5
separate isolation experiments. *Significantly different from DMSO control, P<0.05.
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5.3.2 Identification of 3,5-DCA metabolites in IRCC
Retention times, limits of detection, and extraction coefficients were determined for all
putative metabolites and 3,5-DCA (Figure 25; Table 6), except for 3,5-DCPHA. 3,5-DCPHA is
very unstable and was undetectable after following the processing utilized for all HPLC
experiments.

5.3.3 Metabolism of 3,5-DCA in IRCC
Three separate sets of experiments were conducted in order to determine the metabolism
of 3,5-DCA. This first set of experiments determined the metabolic profile of two different
concentrations of 3,5-DCA (0.5 mM or 1.0 mM) after a 90 minute exposure. Results of these
experiments show that 93.973 ± 5.516% (0.5 mM) and 88.830 ± 5.136% (1.0 mM) of the 3,5DCA dose was found in the media, while 7.300 ± 3.319% (0.5 mM) and 13.530 ± 5.136% (1.0
mM) was found in the cells. As shown in table 7, there were only two minor metabolites detected
in both the media and cell fractions. 3,5-Dichloroacetanilide (3,5-DCAA; 1.863 ± 0.417%) was
detected in the media of all three samples, but was only detected in one of the tissue samples.
3,5-Dichloronitrobenzene (3,5-DCNB; 2.803 ± 2.803%) was detected in the media and cells, but
only in one of three samples. The remaining 3,5-DCA was found as un-metabolized 3,5-DCA.
After exposure to 1.0 mM 3,5-DCA for 90 minutes, 3,5-DCNB was detected in both the media
(1.193 ± 0.566%) and cells (0.340 ± 0.192%) in three samples. 3,5-DCAA was detected in the
media of all four samples, but was undetected in the cells. Once again the remaining 3,5-DCA
was found as the unchanged parent compound. A representative chromatography of 3,5-DCA
metabolism can be seen in figure 26.
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Figure 25. Chromatogram of 3,5-DCA and putative metabolites. Displayed is a representative
chromatogram of a mixture of authentic 3,5-DCA and putative metabolite standards.
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Table 6. Retention times, limits of detection, and extraction efficiency for authenticated
standards of 3,5-dichloroaniline and its putative metabolites.
Compound
4-amino-2,6-dichlorophenol
2-amino-4,6-dichlorophenol
3,5-dichlorophenylhydroxylamine
3,5-dichloroaniline
3,5-dichloroacetanilide
3,5-dichloronitrobenzene

Retention
Time
(min)
3.8
6.1
13.8
24.6
29.4
42.6
57.7
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Limit of
Detection
(ug)
0.0178
0.0178
0.0178
17.8
0.00198
0.0024
0.00192

Extraction
Efficiency
(%)
75.8
100
97.8
0.0
89.5
96.1
79.7

Table 7. Metabolism of 3,5-dichloroaniline (3,5-DCA; 0.5 mM or 1.0 mM; 90 min) in IRCC.
Percentage of dose in media (%)
Compound

0.5 mM 3,5-DCA 1.0 mM 3,5-DCA
(N=3)
(N=4)
4-amino-2,6-dichlorophenol
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
3,5-dichlorophenylhydroxylamine
ND
ND
3,5-dichloroaniline
89.307 ± 6.322
87.133 ± 4.562
3,5-dichloroacetanilide
1.863 ± 0.417
0.505 ± 0.072
3,5-dichloronitrobenzene
2.803^
1.193 ± 0.566*
Total in media
93.973 ± 5.516
88.830 ± 5.136
Percentage of dose in cells (%)
Compound
0.5 mM 3,5-DCA 1.0 mM 3,5-DCA
4-amino-2,6-dichlorophenol
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
3,5-dichlorophenylhydroxylamine
ND
ND
3,5-dichloroaniline
6.823 ± 3.332
13.190 ± 2.122
3,5-dichloroacetanilide
0.067^
ND
3,5-dichloronitrobenzene
0.410^
0.340 ± 0.192*
Total in tissue
7.300 ± 3.319
13.530 ± 5.136
Combined total
101.273 ± 8.834
102.360 ± 6.473
Data is presented as mean ± S.E.M., N as listed in table; ^found in one sample,*found in three
samples. ND means not detected.
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Figure 26. HPLC chromatograms of 3,5-DCA metabolism in IRCC. IRCC were exposed
to either DMSO or 3,5-DCA for 90 minutes. Treatment is listed in each panel.
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Further experiments were conducted to determine the presence of glucuronide and/or
sulfated conjugates following exposure to 1.0 mM 3,5-DCA at two time points [Table 8 (45 min
exposure) or Table 9 (90 min exposure)]. No significant changes in the metabolic profile were
seen after treatment with either β-glucuronidase or arylsulfatase. A change was seen in the total
recovery following the 18 hr incubation required for the glucuronidase and arylsulfatase
experiments. Because of this change further studies into the stability of 3,5-DCA after incubation
for 18 h at 37°C, showed that ~20% of 3,5-DCA is lost during the 18 hr incubation. The stability
of putative metabolites was not determined.
Since previous studies demonstrated that pretreatment with DEDTCA was able to
significantly attenuate 3,5-DCA-induced cytotoxicity in vitro, a final set of experiments was
conducted to explore the effect of DEDTCA pretreatment on 3,5-DCA metabolism. Results of
this study can be found in table 10. As seen with the other experiments conducted in the current
study, the majority of 3,5-DCA was found to be unchanged in both the DEDTCA + 3,5-DCA
treated and 3,5-DCA only treated groups. 3,5-DCNB was detected in two of the four samples and
accounted for 0.305 ± 0.185% of the 3,5-DCA dose in media in the 3,5-DCA only group. In
contrast, 3,5-DCNB was only detected in one of the four samples, and it was only 0.088% of the
3,5-DCA dose (in media), suggesting that the N-oxidation pathway was being inhibited by
DEDTCA pretreatment.
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Table 8. Metabolism of 3,5-DCA (1.0 mM; 45 min) in IRCC.
Percentage of dose in media (%)
Compound
Untreated
Arylsulfatase
β-glucuronidase
treated
treated
4-amino-2,6-dichlorophenol
ND
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
ND
3,5-dichlorophenylhydroxylamine ND
ND
ND
3,5-dichloroaniline
74.515 ± 3.015
51.050 ± 2.330* 58.925 ± 2.715*
3,5-dichloroacetanilide
0.770 ± 0.130
1.290 ± 0.050
ND
3,5-dichloronitrobenzene
ND
ND
ND
Total in media
75.285 ± 3.145
52.340 ± 2.280
58.925 ± 2.715
Percentage of dose in cells (%)
Compound
Untreated
Arylsulfatase
β-glucuronidase
treated
treated
4-amino-2,6-dichlorophenol
ND
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
ND
3,5-dichlorophenylhydroxylamine ND
ND
ND
3,5-dichloroaniline
12.875 ± 2.805
5.315 ± 2.545*
9.400 ± 2.580*
3,5-dichloroacetanilide
ND
ND
ND
3,5-dichloronitrobenzene
ND
ND
ND
Total in tissue
12.875 ± 2.805
5.315 ± 2.545
9.400 ± 2.580
Combined total
88.170 ± 5.940
68.325 + 5.295
57.095 ± 4.385
Data is presented as mean ± S.E.M. N=2. *Uncorrected for ~20% 3,5-DCA loss during 18 hr
incubation. ND means not detected

111

Table 9. Metabolism of 3,5-DCA (1.0 mM; 90 min) in IRCC.
Percentage of dose in media (%)
Compound
Untreated
Arylsulfatase
β-glucuronidase
treated
treated
4-amino-2,6-dichlorophenol
ND
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
ND
3,5-dichlorophenylhydroxylamine ND
ND
ND
3,5-dichloroaniline
75.425 ± 0.895 55.205 ± 3.405* 58.525 ± 4.174*
3,5-dichloroacetanilide
0.7095 ± 0.155 0.895 ± 0.005
ND
3,5-dichloronitrobenzene
ND
ND
ND
Total in media
76.220 ± 1.050 56.100 ± 3.410
58.525 ± 4.174
Percentage of dose in cells (%)
Compound
Untreated
Arylsulfatase
β-glucuronidase
treated
treated
4-amino-2,6-dichlorophenol
ND
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
ND
3,5-dichlorophenylhydroxylamine ND
ND
ND
3,5-dichloroaniline
11.610 ± 2.820 6.055 ± 2.315*
9.380 ± 1.700*
3,5-dichloroacetanilide
ND
ND
ND
3,5-dichloronitrobenzene
ND
ND
ND
Total in tissue
11.610 ± 2.820 6.055 ± 2.315
9.380 ± 1.700
Combined total
87.835 ± 3.665 62.155 ± 1.085
67.910 ± 2.470
Data is presented as mean ± S.E.M. N=2. *Uncorrected for ~20% 3,5-DCA loss during 18 hr
incubation. ND means not detected
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Table 10. Effect of DEDTCA (0.1 mM; 30 min) pretreatment on 3,5-DCA (1.0 mM; 90 min)
metabolism in IRCC.

Compound

Percentage of dose in media (%)
Untreated
DEDTCA pre-treated

4-amino-2,6-dichlorophenol
2-amino-4,6-dichlorophenol
3,5-dichlorophenylhydroxylamine
3,5-dichloroaniline
3,5-dichloroacetanilide
3,5-dichloronitrobenzene
Total in media

ND
ND
ND
ND
ND
ND
89.428 ± 5.656
91.143 ± 3.041
0.498 ± 0.032
0.300 ± 0.052
+
0.305 ± 0.185
0.088^
90.230 ± 5.652
91.530 ± 3.056
Percentage of dose in cells (%)
Compound
Untreated
DEDTCA pre-treated
4-amino-2,6-dichlorophenol
ND
ND
2-amino-4,6-dichlorophenol
ND
ND
3,5-dichlorophenylhydroxylamine
ND
ND
3,5-dichloroaniline
16.010 ± 2.019
14.670 ± 1.782
3,5-dichloroacetanilide
0.018^
ND
3,5-dichloronitrobenzene
0.125^
0.060^
Total in tissue
16.135 ± 2.013
14.730 ± 1.819
Combined total
106.365 ± 6.762 106.260 ± 3.956
Data is presented as mean ± S.E.M. N=4, except ^found in one sample, +found in two samples.

113

5.4 DISCUSSION
3,5-Dichloroaniline (3,5-DCA) has been shown to be the most potent nephrotoxicant
among the dichlorinated anilines both in vivo and in vitro (Lo et al., 1990; Valentovic et al.,
1995a). Further studies in vitro have suggested that 3,5-DCA induced cytotoxicity is at least in
part, due to bioactivation of 3,5-DCA to a toxic metabolite(s) (Racine et al., 2016). Previous
work with aniline and other chloroanilines have shown there to be three major routes of
biotransformation, N-oxidation, phenyl ring oxidation, and N-acetylation (Ehlhardt and Howbert,
1991; Hong and Rankin, 1998). Glucuronide and sulfate conjugates have also been shown to be
major metabolites in aniline and chloroaniline metabolism, in vivo (Hong and Rankin, 1998;
Smith and Williams, 1949; Kao et al., 1978). Based on these studies, the proposed metabolism of
3,5-DCA can be seen in Figure 20.
Results of the current study show that the metabolite arising from N-acetylation, 3,5dichloroacetaniline (3,5-DCAA), was not toxic at the concentrations and time points examined.
This result is in agreement with earlier studies with 3,4-dichloroaniline (3,4-DCA) that show Nacetylation of 3,4-DCA results in a metabolite with reduced nephrotoxic potential as compared to
the parent compound (Rankin et al., 1993, 1995). The results of the HPLC analysis suggests that
3,5-DCAA is a minor metabolite detectable following exposure to 3,5-DCA in IRCC and would
not be expected to contribute significantly to 3,5-DCA cytotoxicity in this model.
In contrast, putative metabolites resulting from phenyl ring oxidation are both
nephrotoxicants. 2-Amino-4,6-dichlorophenol (2A46DCP), which is formed via orthohydroxylation of 3,5-DCA, proved to be nephrotoxic in our IRCC model. However, 2A46DCP
was not formed at detectable levels in the current study. The putative metabolite of 3,5-DCA
which arises from oxidation of 3,5-DCA at the para-position, 4-amino-2,6-dichloropenol
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(4A26DCP), had been shown to be a potent nephrotoxicant in previous studies using a renal
cortical cell model (Rankin et al., 2008a). The current study showed that 4A26DCP is a potent
nephrotoxicant in IRCC, as well. However, further studies with 3,4,5-trichloroaniline have
shown that the addition of chlorine at the para-position, which would inhibit para-oxidation,
leads to increased nephrotoxicity (Racine et al., 2014), suggesting that 4A26DCP, while a toxic
compound, most likely does not play a significant role in 3,5-DCA induced nephrotoxicity. As
seen with 2A46DCP, 4A26DCP was not detected by HPLC analysis. These results suggest that
while phenyl-ring oxidation would ppotentially lead to potent nephrotoxicants, it is not a major
metabolic pathway of 3,5-DCA in IRCC.
N-Oxidation has also been shown to be an important pathway of chloroaniline
metabolism (Hong and Rankin, 1998; Ehlhardt and Howbert, 1991). A previous study has
suggested that N-oxidation may play a significant role in 3,5-DCA induced nephrotoxicity in
IRCC (Racine et al., 2016). There are three major metabolites that can arise via N-oxidation of
3,5-DCA, as shown in figure 20; 3,5-dichlorophenylhydroxylamine (3,5-DCPHA), 3,5dichloronitrosobenzene (3,5-DCNSB), and 3,5-dichloronitrobenzene (3,5-DCNB). The
nephrotoxic potential of two of these metabolites, 3,5-DCNB and 3,5-DCPHA, was determined
in the current study. The third, 3,5-dichloronitrosobenzene, is highly unstable and for that reason
no experiments were conducted using it. Both 3,5-DCNB (Figure 22) and 3,5-DCPHA (Figure
23) proved to be more potent nephrotoxicants than 3,5-DCA (Racine et al., 2016), suggesting
that both may contribute to 3,5-DCA induced nephrotoxicity in IRCC if formed. HPLC analysis
was unable to detect 3,5-DCPHA. However, 3,5-DCNB is a minor metabolite of 3,5-DCA in
IRCC. The presence of 3,5-DCNB suggests that 3,5-DCA undergoes N-oxidation in IRCC.
Additional studies showed that pretreatment of IRCC with DEDTCA, a selective CYP2C
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inhibitor, led to a decrease in the production of 3,5-DCNB, indicating that the N-oxidation
pathway for the 3,5-DCA was inhibited by DEDTCA. Earlier studies with DEDTCA
pretreatment led to a significant attenuation of 3,5-DCA-induced nephrotoxicity in IRCC (Racine
et al., 2016). Combining these observations supports a role for N-oxidation in 3,5-DCA-induced
toxicity, in vitro.
5.5 CONCLUSION
This study was designed to explore the nephrotoxic potential of putative metabolites of
3,5-dichloroaniline (3,5-DCA), since previous studies with 3,5-DCA suggested that metabolites
contributed to 3,5-DCA induced cytotoxicity, at least in part. Since toxicity with 3,5-DCA
required a concentration of 1.0 mM for 90 minutes, the results of the current study suggest that
3,5-DCNB, 3,5-DCPHA, 2A46DCP, and 4A26DCP are nephrotoxicants in vitro and may
contribute to 3,5-DCA induced nephrotoxicity. However previous work has suggested that
4A26DCP most likely does not contribute (Racine et al., 2014). Furthermore, HPLC analysis
showed that there is minimal detectable metabolism of 3,5-DCA in IRCC. In fact, only two
minor metabolites were detected, 3,5-DCAA and 3,5-DCNB. 4A26DCP, 2A46DCP, and 3,5DCPHA were not formed in detectable levels in this study. Also absent in this study was the
detection of glucuronidated or sulfonated conjugates. These data, along with previous studies
that showed metabolites contribute to 3,5-DCA-induced nephrotoxicity, suggest that the ultimate
toxic metabolite(s) is/are extremely potent and is/are most likely formed close to its molecular
target. Future studies are required to determine the molecular target(s) and mechanism of cellular
death for 3,5-DCA.
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CHAPTER V: CONCLUSIONS AND FUTURE DIRECTIONS
Chloroanilines are important intermediates in the production of a variety of agricultural
and industrial compounds (Kahl et al., 2011). Exposure to chloroanilines has been associated
with hematotoxicity (Nomura, 1975; Pizon et al., 2009; Valentovic et al., 1997), splenotoxicity
(Gralla et al., 1979; Bus, 1983; Kahn et al., 1993), and nephrotoxicity (Rankin et al., 1986; Lo et
al., 1990). 3,5-DCA was shown to be the most potent nephrotoxicant of the mono- and
dichlorinated anilines both in vivo and in vitro, using renal cortical cells (Rankin et al., 1986; Lo
et al., 1990; Valentovic et al., 1995a). In vivo, 3,5-DCA induced nephrotoxicity is characterized
by proximal tubular cell necrosis, increased BUN concentration, kidney weight, proteinuria, and
hematuria (Rankin et al., 1986; Lo et al., 1990). In vitro studies have shown that LDH release is
significantly increased and organic ion accumulation is significantly decreased following
exposure to 3,5-DCA in renal cortical slices from rats (Valentovic et al., 1995a; Lo et al., 1990).
Studies have also shown one putative metabolite of 3,5-DCA, 4A26DCP, possesses increased
nephrotoxic potential both in vivo and in vitro, when compared to the parent compound 3,5-DCA
(Rankin et al., 1994). 4A26DCP is formed via phenyl ring hydroxylation, which has been shown
to be a major metabolic pathway in aniline metabolism (Kao et al., 1978; Parke, 1960). However,
the role of metabolism in 3,5-DCA-induced nephrotoxicity had yet to be explored in any great
detail. The work presented in this thesis was designed to fill this void in knowledge.
Initial studies were designed to explore the nephrotoxic potential of 3,5-DCA in isolated
renal cortical cells (IRCC). IRCC was chosen as the model for multiple reasons. Firstly, IRCC
are enriched for proximal tubular cells, the target cell type in 3,5-DCA-induced nephrotoxicity in
vivo (Lash, 1998). Secondly, IRCC have been shown to maintain their metabolic enzyme activity
(Cummings et al., 1999). As summarized in Chapter 2, 3,5-DCA was capable of significantly
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increasing lactate dehydrogenase (LDH) release, a marker of cytotoxicity, in a concentration and
time dependent manner. Cytotoxicity was evident at concentrations as low as 0.5 mM after 120
minutes exposure, and as early as 90 minute at 1.0 mM. Since previous studies had suggested
that putative metabolites of 3,5-DCA possessed increased nephrotoxicity, further studies were
conducted to determine the role of renal metabolism in 3,5-DCA induced cytotoxicity. For these
studies, IRCC were pretreated with inhibitors of biotransforming enzymes prior to exposure to
1.0 mM 3,5-DCA for 90 minutes. Inhibition of the CYP2C, FMO, and peroxidase activity was
able to significantly attenuate toxicity, suggesting that renal metabolism contributes to
cytotoxicity, especially metabolic pathways which facilitate N-oxidation.
Since renal metabolism of 3,5-DCA was indicated to play a role in cytoxicity in IRCC,
further studies were conducted to determine the ultimate toxicant(s) following exposure to 3,5DCA. The first set of experiments can be found in chapter 4. In these experiments the role of
para-hydroxylation of 3,5-DCA was determined. The nephrotoxic potential of TCA was
determined in IRCC from male Fischer 344 rats. TCA was used because the addition of a
chlorine on the para-position effectively inhibits para-hydroxylation. In these studies TCA was
shown to significantly increase LDH release at concentrations as low as 0.1 mM after 120
minutes and 0.5 mM after 90 minutes. When compared with 3,5-DCA cytotoxicity, TCA was
shown to be a more potent nephrotoxicant. These data indicate that blocking the para-position to
hydroxylation produces a compound with greater nephrotoxic potential than 3,5-DCA. Thus,
production of 4A26DCP would not be the major bioactivation pathway for 3,5-DCA in IRCC,
and that while 4A26DCP is a potent nephrotoxicant in renal cortical slices, it is unlikely that it
plays a significant role in 3,5-DCA-induced in vitro nephrotoxicity. However, more studies were
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required to determine the nephrotoxic potential of additional putative metabolites of 3,5-DCA
and to determine 3,5-DCA metabolism in IRCC.
The nephrotoxic potential of five putative metabolites of 3,5-DCA in IRCC can be found
in chapter 4. The metabolites tested were 3,5-DCAA, 3,5-DCPHA, 3,5-DCNB, 4A26DCP, and
2A46DCP. These metabolites arise from N-acetylation, N-oxidation, and phenyl ring oxidation,
all known pathways of aniline and chloroaniline metabolism (Kao et al., 1978; Parke, 1960;
Ehlhardt and Howbert, 1991; Harrison and Jollow, 1986; 1987). Results of this study
demonstrated that 3,5-DCPHA, 3,5-DCNB, 4A26DCP, and 2A46DCP were all nephrotoxicants
at either concentrations or exposure times less than that of the parent compound 3,5-DCA, as
measured by LDH release. These data suggest that any or all four of these metabolites could
contribute to 3,5-DCA cytotoxicity; however, as previously discussed it is highly unlikely that
4A26DCP would contribute. In contrast, 3,5-DCAA was not cytotoxic at any of the
concentrations or time points tested. This result matches previous studies with 3,4dichloroacetanilide that showed the acetylated metabolite possessed a much lower nephrotoxic
potential than the parent compound 3,4-dichloroaniline (Rankin et al., 1993; 1995).
While it is widely accepted that biotransformation enzymes are found at higher
concentrations in the liver, the kidney has been shown to possess many of the same enzymes
(Cashman, 1995; Cummings et al., 1999; Kimura et al., 1989a, 1989b; Dolphin et al., 1991). One
study suggested that the renal biotransformation enzyme activity is between 15-40% of hepatic
biotransformation enzyme activity (Litterst, Mimnaugh, Reagan, and Gram, 1975). For the
current study, it was hypothesized that renal metabolism of 3,5-DCA played a role in 3,5-DCA
induced nephrotoxicity, despite the lower levels of biotransformation enzymes found in renal
tissue, as compared to the liver, since any resulting toxic metabolite(s) is produced in the target
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tissue. The results of the current study showed minimal renal metabolism of 3,5-DCA in IRCC.
In fact, only two metabolites were found, 3,5-DCAA and 3,5-DCNB. Furthermore, the formation
of 3,5-DCNB and the ability of DEDTCA to not only limit 3,5-DCNB’s formation but also to
attenuate 3,5-DCA cytotoxicity strongly support N-oxidation as a contributing pathway in 3,5DCA induced nephrotoxicity in IRCC.
Preliminary studies into the mechanism of cell death in 3,5-DCA induced cytotoxicity
have also been conducted. It was initially hypothesized that free radical induced oxidative stress
may be the mechanism of cell death in 3,5-DCA induced nephrotoxicity, since earlier studies
demonstrated multiple antioxidants (glutathione, ascorbate, N-acetyl-L-cysteine, pyruvate, and
α-tocopherol) were able to significantly attenuate cytotoxicity in IRCC (Racine et al., 2016).
However, additional experiments showed that oxidative stress was only present following the
exposure to toxic levels of 3,5-DCA, as previously discussed in Chapter 2, suggesting that
oxidative stress was a consequence of toxicity rather than the mechanism of cell death. Since
minimal metabolism and oxidative stress were detected in IRCC following exposure to 3,5-DCA,
yet inhibitors of biotransforming enzymes and antioxidants significantly attenuate cytotoxicity, it
is further hypothesized that the ultimate toxicant(s) species of 3,5-DCA is most likely a highly
reactive radical and/or alkylating intermediate arising via N-oxidation, formed close to its
molecular target(s).
One potential molecular target for 3,5-DCA is the mitochondria. Previous studies with 4chloroaniline (4-CA) and 2-chloroaniline (2-CA) found the presence of both 4-CA and 2-CA in
mitochondrial fractions of renal cortical slices from male Fischer 344 rats given a single i.p.
injection of [14C]-4CA or [14C]-2CA (0.5 or 1.0 mM) three hours post injection (Dial, Anestis,
Kennedy, and Rankin, 1998). Studies with submitochondrial particles (SMP) from beef heart
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mitochondria showed increased toxicity with increased chlorine substitution of aniline (Argese et
al., 2001). SMP are stable preparations of inverted inner mitochondrial membrane, which
maintain mitochondrial respiration functions. The SMP assay is based on the process of
reverse electron transfer that can be negatively affected by inhibitors and/or uncouplers of
electron transport. One downfall of this assay is that any compound that affects membrane
integrity can also negatively affect the assay (Argese et al., 2001). While there have been some
studies exploring mitochondrial dysfunction with a few select chloroanilines, the role of
mitochondrial dysfunction in 3,5-DCA and 3,5-DCA metabolite-induced nephrotoxicity has yet
to be determined. To that end, the molecular target of 3,5-DCA could be explored by exposing
IRCC to 14C isotopically labeled 3,5-DCA. Following exposure, the subcellular location of 3,5DCA can be determined using methods described in Dial et. al (1998). It is hypothesized that a
fraction of radioactivity will be found in the mitochondria following exposure to 3,5-DCA.
To further explore mitochondrial involvement in 3,5-DCA-induced cytotoxicity,
mitochondrial dysfunction can be determined following exposure to 3,5-DCA. One way to
determine mitochondrial dysfunction would be by measuring mitochondrial respiration of IRCC,
using a Seahorse XF cell mito stress test, with some modifications. In these experiments, IRCC
would be exposed to various concentrations of 3,5-DCA (0.0, 0.5, 1.0 mM) for either 60 or 90
minutes. Following exposure IRCC can be seeded and loaded on to the Seahorse XF cell mito
stress test 96 well plate at a density of 3.0 x 105 cells/well in triplicate and then analyzed
following the manufacturer’s protocol. One downfall of the Seahorse XF cell mito stress test,
which could limit its ability to determine the effect of 3,5-DCA on mitochondria function, is the
viability of the IRCC. In the case that IRCC viability limits the use of Seahorse XF cell mito
stress test, further studies could be performed using HK-2 cells, which have been shown to be
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another model for renal toxicity. While cellular respiration is the best measure of mitochondrial
dysfunction, another way to measure mitochondrial dysfunction is to determine the expression,
concentration, and activity of electron transport complexes, using western blot analysis (Brand
and Nicholls, 2011). In these experiments, IRCC would be exposed to 3,5-DCA (0.0, 0.5, 1.0
mM; 60 or 90 min). Following exposure, an aliquot of cells can be taken, prepared, and analyzed
using commercially available western blot kits. The two main electron transport complexes,
which are measured to explore mitochondrial dysfunction, are complex I and complex IV (Brand
and Nicholls, 2011). If mitochondria are the molecular target of 3,5-DCA in IRCC, as
hypothesized, not only would significant increases in LDH release be observed but significant
decreases in the mitochondrial respiration, as well as the expression, concentration, and activity
of complex IV and I should also be observed. Mitochondrial function of IRCC following
exposure to 3,5-DCA metabolites should also be determined using the same methods as
described for 3,5-DCA.
The purpose of the current studies was to explore the nephrotoxic potential of 3,5-DCA
in IRCC, determine the role of metabolism in 3,5-DCA-induced nephrotoxicity, and explore
oxidative stress as a potential mechanism of cell death. In the current studies, 3,5-DCA proved to
be nephrotoxic in IRCC from male Fischer 344 rats. Further studies suggested that metabolism
of 3,5-DCA contributes to nephrotoxicity, at least in part. These studies suggested that Noxidation of 3,5-DCA is most likely the major contributing metabolic pathway, as determined by
the ability of inhibitors of N-oxidation to significantly reduce both the formation of 3,5-DCNB
and the release of LDH following exposure to 3,5-DCA. These data suggest that the ultimate
toxicant is most likely a highly toxic and highly reactive radical intermediate formed via Noxidation. However, further studies are required to determine the ultimate toxicant. The results of

123

the current study also suggested that oxidative stress is not the mechanism of cell death in 3,5DCA-induced toxicity but rather a result of toxicity. Therefore, further studies are required to
determine the mechanism of cell death, as well as any molecular targets of 3,5-DCA-induced
cytotoxicity.

124

REFERENCES
Aizawa, H., 1989. Metabolic Maps of Pesticides. Academic Press. London, UK. Vol. 2, p27-42
Acara, M., Gessner, T., Greizerstein, H., Trudnowski, R., 1981. Renal N-oxidation of meperidine
by the perfused kidney of the rat. Drug. Metab. Dispos. 9, 75-79.
Aggarwal, N., Kumar, R., Dureja, P., Rawat, D.S., 2009. Schiff bases as potential fungicides and
nitrification inhibitors. J. Agric. Food Chem. 57, 8520-8525.
Anderson, M.E., 1985. Determination of glutathione and glutathione disulfide in biological
samples. Meth. Enzymol. 113, 548–55.
Argese, E., Bettiol, C., Agnoli, F., Zambron, A., Mazzola, M., Ghirardini, A.V., 2001.
Assessment of chloroaniline toxicity by the submitochondrial partical assay. Environ. Toxicol.
And Chem. 20(4), 826-832.
Axelrod, J. 1955. The enzymatic demethylation of ephidrine. Journal of Pharmacology. 114,
430-438.
Bakkenist, A., Plat, H., Wever, R., 1981. Oxidation of 4-chloroaniline catalyzed by human
myeloperoxidase. Bioorganic Chemistry. 10, 324-328.
Baliga, R., Zhang, Z., Baliga , M., Ueda, N., Shah, S.V., 1998. Role of cytochrome P-450 as a
source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int. 54, 1562–9.
Bartha, R., Pramer, D., 1967. Pesticide transformation to aniline and azo compounds in soil.
Science. 156(3782)1617-1618.
Bartha, R., 1968. Biochemical transformations on anilide herbicides in soil. J. Agric. Food
Chem. 16(4), 602-604.
Boehncke, A., Kielhorn, J., Konnecker, G., Pohlenz-Michel, C., Mangelsdorfer, I., 2003.
Concise International Chemical Assessment Document 48 – 4-Chloroaniline. World Health
Organization: Geneva, Switzerland.
Bohme, C., Grunow, W., 1969. The metabolism of carbamate herbicides in the rat. Metabolism
of m-chloroaniline as a constituent of chloropham and barban. Food and Cosmetic Toxicology.
7,125-133.
Bradford, L.D., 2002. CYP2D6 allele frequency in European caucasions, asians, aftricans, and
their descendants. Pharmacogenomics 3(2), 229-243.
Bradford , M.M., 1976. A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–54.

125

Brand, M.D., Nicholls, D.G., 2011. Assessing mitochondrial dysfunction in cells. Biochem J.
435, 297-312.
Britton, R.S., 1996. Metal-induced hepatotoxicity. Semin Liver Dis. 16(1), 3-12.
Brodie, B., Axelrod, J., Cooper, J.R., Gaudette, L., LaDu, B.N., Mitoma, C., Udenfriend, S.,
1955. Detoxication of drugs and other foreign compounds by liver microsomes. Science. 121,
603-604.
Bus, J.S., 1983. Aniline and nitrobenzene: erythrocyte and spleen toxicity. CIIT Activities 3(12),
1, 6.
Bus, J.S., Popp, J.A., 1987. Perspectives on the mechanism of action of the splenic toxicity of
aniline and structurally-related compounds. Food Chem. Toxicol. 25(8), 619-626.
Casado de Frias, E., Andujar, P.H., Oliete, F., Diaz, I.S., 1983. Intoxication caused by ingestion
of rape oil denatured with aniline. Am. J. Dis. Child. 137(10), 988-991.
Cashman, J.R., 1995. Structural and catalytic properties of the mammalian flavin
monooxygenase. Chem Res. Toxicol. 8, 165-181.
Cashman, J.R., 1999. In vitro metabolism: FMO and related oxygenations, in Wolf TF (ed)
Handbook of Drug Metabolism. New York. Marcel Dekker. p477-505.
Campos, M., Perruchon, C., Vasilieiadis, S., Menkissoglu-Spiroudi, U., Karpouzas, D.G., Diez,
M.C. 2015. Isolation and characterization of bacteria from acidic pristine soil environment able
to transform ipodione and 3,5-dichloroaniline. International Biodeterioration and
Biodegradation 104; 201-211.
Chhabra R.S., Thompson M., Elwell M.R., Gerken D.K., 1990. Toxicity of p-chloroaniline in
rats and mice. Food and Chemical Toxicology. 28, 712-722.
Chojkier, M., Houglum, K., Solis-Herruzo, J., Brenner, D.A., 1989. Stimulation of collagen gene
expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation. J. Biol.
Chem. 264, 16957-16962.
Christiansen, W., 1923. N-Methyl-para-amino-ortho-chlorophenol sulfate, a new photographic
developer. J. Am. Chem. Soc. 45, 2192-2194.
Corbett, M.D., Chipko, B.R., Batchelor, A.O., 1980. The action of chloride peroxidase on 4chloroaniline. N-oxidation and ring halogenation. Biochem. J 187, 893–903.
Craciunescu, D.G., Furlani, A., Scarcia, V., Ghirvu, C., Doadrio, A., 1985. On the synthesis,
cytostatic and antitumor properties of new Pt(II) and Pt(IV) complexes with chloroanilines.
Chem. Biol. Interact. 53, 45-56.

126

Cribb, A.E., Spielberg, S.P., Griffin, G.P., 1995. N4-hydroxylation of sulfamethoxazole by
cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole
hydroxylamine in human and rat hepatic microsomes. Drug Metab. Dispos. 23, 406–14.
Cummings, B.S., Zangar, R.C., Novak, R.F., 1999. Cellular distribution of cytochromes P-450
in the rat kidney. Drug metabolism and Disposition 27, 542-548.
Davis, J.M., Emslie, K.R., Sweet, R.S., Walker, L.L., Naughton, R.J., Skinner, S.L., Tange, J.D.,
1983. Early functional and morphological changes in renal tubular necrosis due to paminophenol. Kidney Int. 24, 740-747.
Dawson, J.H., 1988. Probing structure-function relations in heme-containing oxygenases and
peroxidaess. Science 240:433-439.
Dayer, P., Desmeules, J., Leemann, T., Striberni, R., 1988. Bioactivation of the narcotic drug
codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine
4-hydroxylation (cytochrome P450 dbl.bufI). Biochem. Biophys. Res. Commin. 152, 411-416.
Demers, FX, Yates, RL. 1977. Antimicrobials: identification of 3,4,4’-trichlorocarbanilide and
4,4’-dichloro-3-(tricluoromethyl) carbanilide in deodorant bars. J. Soc. Cosmet. Chem. 28, 659666.
De Wolf W., Seinen W., Hermens J.L.M. 1993. Biotransformation and toxicokinetics of
trichloroanilines in fish in relation to their hydrophobicity. Arch. Environ. Contam.
Toxicol. 25,110–117.
Dial, L.D., Anestis, D.K., Kennedy, S.R., Rankin, G.O., 1998. Tissue distribution, subcellular
location and covalent binding of 2-chloroaniline and 4-chloroaniline in Fischer 344 rats.
Toxicology. 131, 109-119.
Dolphin, C., Shephard, E.A., Povey, S., Palmer, C.N., Ziegler, D.M., Ayesh, R., Smith, R.L.,
Phillips, I.R., 1991. Cloning, primary sequence, and chromosomal mapping of a human flavincontaining monooxygenase (FMO1). J. Biol. Chem. 266(19), 12379-12385.
Eagling, V.A., Tjia, J.F., Back, D.J., 1998. Differential selectivity of cytochrome P450 inhibitors
against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol 45, 107–14.
Ehlhardt, W.J., 1991. Metabolism and dispositon of the anticancer agent sulfenur in mouse, rat,
monkey, and human. Drug Meab. Dispos. 19, 370-375.
Ehlhardt, W.J., Howbert, J.J., 1991. Metabolism and disposition of p-chloroaniline in rat, mouse,
and monkey. Drug Metab. Dispos. 19, 366–9.
Eling, T.E., Thompson, D.C., Foureman, G.L., Curtis, J.F., Hughes, M.F., 1990. Prostaglandin H
synthase and xenobiotic oxidation. Annu. Rev. Pharmacol. Toxicol. 30, 1-45.

127

Elson, L.A., Goulden, F., Warren, F.L., 1946. Biochem. J. 40, xxix.
Entsch, B., van Berkel, W.J., 1995. Structure and mechanism of para-hydroxybenzoate
hydroxylase. FASEB J. 9(7), 476-483.
Eyer, P., Ascherl, M., 1987. Reactions of para-substituted nitrosobenzenes with human
hemoglobin. Biol. Chem. Hoppe-Seyler 368, 285–94.
Faivre, M., Armand, J., Evreux, J.C., Duvermeuil, G. Colin, C., 1971. Toxic methemoblobinemia
caused by aniline derivatives: parachloroaniline and paratoluidine (2 cases). Arch. Mal. Prof.
32(9), 575-577.
Fowler, L.M., Moore, R.B., Foster, J.R., Lock, E.A., 1991. Nephrotoxicity of 4-aminophenil
glutathione conjugate. Hum. Exp. Toxicol. 10, 451-459.
Fowler, L.M., Foster, J.R., Lock, E.A., 1993. Effect of ascorbic acid, acivicin, and probenecid on
the nephrotoxicity of 4-aminophenol in the Fischer 344 rat. Arch. Toxicol. 67, 613-621.
Garfinkel, D., 1958. Studies on pig liver microsomes. I. enzymic and pigment composition of
different microsomal fractions. Archives of Biochemistry and Biophysics. 77, 493-509.
Gartland, K.P.R., Bonner, F.W., Trimbell, J.A., Nicholson, J.K., 1989. Biochemical
characterisation of para-aminophenol-induced nephrotoxic lesions in F344 rat. Arch. Toxicol.
63,97-106.
Geesin, J.C., Brown, L.J., Gordon, J.S., Berg, R.A., 1993. Regulation of collagen synthesis in
human dermal fibroblasts in contracted collagen gels by ascorbic acid, growth factors, and
inhibitors of lipid peroxidation. Exp. Cell Res. 206, 283-290.
Golly, I., Hlavica, P., 1985. N-Oxidation of 4-chloroaniline by prostaglandin synthase. Redox
cycling of radical intermediate(s). Biochem. J. 226, 803–9.
Gonzalez, F.J., 1989. The molecular biology of cytochrome P450. Pharmacol. Rev. 40(4), 243288.
Goodman, D.G., Ward, J.M., Reichardt, W.D., 1984. Splenic fibrosis and sacomas in F344 rats
fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine
hydrochloride, 4,4’-sulfonyldaniline, of D & C red No. 9. J. Natl. Cancer Inst. 73(1), 265-273.
Gosselin, R.E., Smith, R.P., Hodge, H.C., 1984. Clinical Toxicology of Commercial Products. 5th
ed. Baltimore: Williams and Wilkins, p. III- 33-36.
Gralla, E.J., Bus, J.S., Reno, F., Cushman, J.R., Ulland, B.N., 1979. Studies of aniline HCL in
rats. Toxicol. Appl. Pharmacol. 48, A97.

128

Graubarth, J., Bloom, C.J., Coleman, F.C., Solomon, H.N. 1945. Dye Poisoning in the Nursery.
J. Am. Med. Assoc. 128, 1155.
Griffith, O.W., 1980. Determination of glutathione and glutathione disulfide using glutathione
reductase and 2-vinylpyridine. Anal. Biochem. 106, 207–12.
Groves, C.E., Sheevers, H.V., McGuiness, S.J., 1994. Renal organic ion transport, in In vitro
toxicity indicators (eds Tyson, C.A., Frezier, S.M.) Academic Press San Diego, CA. 108-120.
Guengerich, F.P., 1987. Mammalian Cytochrome P450. Baca Raton, FL. CRC Press.
Guengerich, F.P., 2008. Cytochrome P450 and chemical toxicology. Chem. Res. Toxicol. 21, 7083.
Guilhermino, L., Soares, A.M., Carvalho, A.P., Lopes, M.C., 1998. Acute effects of 3,4dichloroaniline on blood of male Wistar rats. Chemosphere 37, 619–32.
Hardwick, J.P., Song, B.J., Hubeman, E., Gonzalez, F.J., 1987. Isolation, complementary DNA
sequence and regulation of rat hepatic luric acid ω-hydroxylase (cytochrome P450 LA omega):
Identification of a new cytochrome P450 gene family. J. Biol. Chem. 262, 801-810.
Harleton, E., Webster, M., Bumpus, N.N., Kent, U.M., Rae, J.M., Hollenberg, P.F. 2004.
Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the
inactivation of both isoforms by two distinct mechanisms. J. Pharmacol. Exp. Ther. 310, 10111019.
Harmon, R.C., Terneus, M.V., Kiningham, K.K., Valentovic, M., 2005. Time-dependent effect
of p-aminophenol (PAP) toxicity in renal slices and development of oxidative stress. Toxicol.
Appl. Pharmacol. 209, 86–94.
Harmon, R.C., Kiningham, K.K., Valentovic, M.A., 2006. Pyruvate reduces 4-aminophenol in
vitro toxicity. Toxicol. Appl. Pharmacol. 213, 179–86.
Harrison, J.H., Jollow, D.J., 1983. Rapid and sensitive method for microassay of nitrosobenzene
plus phenylhydroxylamine in blood. J. Chromatogr. 277, 173-182.
Harrison, J.H., Jollow, D.J., 1986. Role of aniline metabolites in aniline-induced hemolytic
anemia. The Journal of pharmacology and experimental therapeutics 238, 1045–54.
Harrison, J.H., Jollow, D.J., 1987. Contribution of aniline metabolites to aniline-induced
methemoglobinemia. Molecular pharmacology 32, 423–31.
Hofmann, A.W., 1843. Chemical investigation of organic bases in coal tar oil. Annalen. der
Chemie. und Pharmacie. 47, 37-87.

129

Hong, S.K., Valentovic, M.A., Anestis, D.K., Ball, J.G., Brown, P.I., Rankin, G.O., 1996.
Nephrotoxicity of 4-amino-2-chlorophenol and 2-amino-4-chlorophenol in the Fischer 344 rat.
Toxicology 110, 47–58.
Hong, S.K., Anestis, D.K., Ball, J.G., Valentovic, M.A., Brown, P.I., Rankin, G.O., 1997. 4Amino-2,6-dichlorophenol nephrotoxicity in the Fischer 344 rat: protection by ascorbic acid,
AT-125, and aminooxyacetic acid. Toxicol. Appl. Pharmacol. 147, 115–25.
Hong, S.K., Rankin, G.O., 1998. Biotransformation of 2-chloroaniline in the Fischer 344 rat:
identification of urinary metabolites. Xenobiotica 28, 985–94.
Hong, S.K., Anestis, D.K., Henderson, T.T., Rankin, G.O., 2000. Haloaniline-induced in vitro
nephrotoxicity: effects of 4-haloanilines and 3,5-dihaloanilines. Toxicol. Lett. 114, 125–33.
Hong, S.K., Anestis, D.K., Ball, J.G., Valentovic, M.A., Rankin, G.O., 2002. In vitro
nephrotoxicity induced by chloronitrobenzenes in renal cortical slices from Fischer 344 rats.
Toxicology letters. 129(1-2), 133-141.
Imai, K., Takahashi, O., Watanabe, K., Nakazawa, S., Yamanaka, H., 1991. The effects of
antiprostatic agents on the accessory sex organs of rats treated with adrenal androgens.
Hinyokika Kiyo. 37, 1669-1676.
Ioannides, C., Park, D.V., 1990. The cytochrome P450 I gene family of microsomal
hemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev. 22, 1-85.
Jenkins, F.P., Robinson, J.A., Gellatly, J.B., Salmond, G.W., 1972. The no-effect dose of aniline
in human subjects and a comparison of aniline toxicity in man and the rat. Food Cosmet. Toxicol.
10(5), 671-679.
Jokanovic, M., 2001. Biotransformation of organophosphate compounds. Toxicology 166, 139160.
Jones, D.P., Sundby, G.B., Ormstad, K., Orrenius, S., 1979. Use of isolated kidney cells for
study of drug metabolism. Biochemical pharmacology. 28, 929-935.
Kahl, T., Schroder, K.W., Lawerence, F.R., Marshall, W.J., Hoke, H., Jackh, R., 2011. Aniline,
in Ulmann’s Encylcopdedia of Industrial Chemistry.
Kao, J., Faulkner, J., Bridges, J.W., 1978. Metabolism of aniline in rats, pigs, and sheep. Drug
Metab. Dispos. 6(5), 549-555.
Katsuda, H., Yamashita, M., Katsura, H., Yu, J., Waki, Y., Nagata, N., Sai, Y., Miyamoto, K.-I.,
2010. Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor
activity. Biol. Pharm. Bull. 33, 1867–71.

130

Kearney, P.C., Plimmer, J.R., 1972. Metabolism of 3,4-dichloroaniline in soils. J. Agric. Food
Chem. 20(3), 584-585.
Khan, SU, Marriage PB, Saidak, WJ. 1976. Persistence and movement of diuron and 3,4dichloroaniline in an orchard soil. Weed Science. 24(6), 583-586.
Khan, M.F., Kaphalia, B.S., Boor, P.J., Ansari, G.A., 1993. Subchronic toxicity of aniline
hydrochloride in rats. Arch. Environ. Contam. Toxicol. 24(3), 368-374.
Khan, M.F., Kaphalia, B.S., Ansari, G.A., 1995a. Erythrocyte-aniline interaction leads to their
accumulation and iron deposition in rat spleen. J. Toxicol. Environ. Health. 44(4), 415-421.
Khan, M.F., Boor, P.J., Kaphalia, B.S., Alcock, N.W., Ansari, G.W., 1995b. Hematopoitic
toxicity of linoleic acid anilide: importance of aniline. Fundam. Appl. Toxicol. 25(2), 224-232.
Khan, M.F., Boor, P.J., Alcock, N.W., Ansari, G.A., 1997a. Oxiative stress in the splenotoxicity
of aniline. Fundam. Appl. Toxicol. 35(1), 22-30.
Khan, M.F., Wu, X., Kaphalia, B.S., Boor, P.J., Ansari, G.A., 1997b. Acute hematopoietic
toxicity of aniline in rats. Toxicol. Lett. 92(1), 31-37.
Khan, M.F., Wu, X., Boor, P.J., Ansari, G.A., 1999. Oxidative modification of lipids and
proteins in aniline-induced splenic toxicity. Toxicol. Sci. 48(1), 131-140.
Khan, M.F., Wu, X., Alcock, N.W., Boor, P.J., Ansari, G.A., 1999. Iron exacerbates anilineassociated splenic toxicity. J. Toxicol. Environ. Health A. 57(3), 173-184.
Khan, M.F., Wu, X., Ansari, G.A., 2000. Contribution of nitrosobenzene to splenic toxicity of
aniline. Journal of toxicology and environmental health. Part A 60, 263–73.
Kiese, M., Taeger, K., 1976. The fate of phenylhydroxylamine in human red cells. Naunyn
Schmiedebergs Arch. Pharmacol. 292, 59–66.
Kimura, S., Hanioka, N., Matsunga, E., Gonzalez, F.J., 1989a. The rat clofibrate-inducible
CYP4A gene subfamily I. Complete intron and exon sequence of the CYP4A2 genes, unique
exon organization, and identification of a conserved 19-bp upstream element. DNA 8, 503-516.
Kimura, S, Hardwick, J.P., Kozak, C.A., Gonzalez, F.J., 1989b. The rat clofibrate-inducible
CYP4A subfamily II. cDNA sequence of IVA3, mapping of the CYP4A locus to mouse
chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8, 517525.
Klingenberg, M., 1958. Pigments of rat liver microsomes. Archives of Biochemistry and
Biophysics. 73, 376-386.

131

Kobayashi, K., Urashima, K., Shimada, N., Chiba, K., 2003. Selectivities of human cytochrome
P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Drug
Metab. Dispos. 31, 833–6.
Koh, A.S., Simmons-Willis, T.A., Pritchard, J.B., Grassel, S.M., Ballatori, N., 2002.
Identification of a mechanism by which the methylmercury antidotes N-actylcysteine and
dimercaptopropanesulfonate enhance urinary metal excretion: Transport by the renal organic
anion transporter. Mol. Pharmacol. 62, 921-926.
Kosek, J.C., Mazze, R.I., Cousins, M.J., 1974. Nephrotoxicity of gentamicin. Lab Invest 30(1),
48-57.
Kubo, A., Itoh, S., Itoh, K., Kamataki, T., 1997. Determination of FAD-binding domain in
flavin-containing monooxygenase (FMO1). Arch. Biochem. Biophys. 345(2), 271-277.
Kutting, B., Goen, T., Schwegler, U., Fromme, H., Uter, W., Angerer, J., Drexler, H., 2009.
Monoarylamines in the general population-A cross-sectional population-based study including
1004 Bavarian subjects. Int. J. Hyg. Environ. Health. 212, 298-309.
Laine, J.E., Auriola, S., Pasanen, M., Juvonen, R.O., 2009. Acetaminophen bioactivation by
human cytochrome P450 enymes and animal microsomes. Xenobiotica. 39(1), 11-21.
Lash, L.H., 1998. In vitro methods of assessing renal damage. Toxicologic Pathology 26, 33-42.
Lash, L.H., 2011. Renal membrane transport of glutathione in toxicology and disease. Vet. Path.
48, 408-419.
Lau, S.S., Monks, T.J., 1987. Co-oxidation of 2-bromohydroquinone by renal prostaglandin
synthase. Modulation of prostaglandin synthesis by 2-bromohydroquinone and glutathione. Drug
Metab. Dispos. 15, 801–7.
Lauterburg, B.H., Corcoran, G.B., Mitchell, J.R., 1983. Mechanism of action of N-acetylcysteine
in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J. Clin. Invest. 71,
980-991.
Lawton, M.P., Philpot, R.M., 1993. Functional characterization of flavin-containing
monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of
proposed FAD- and membrane-binding domains. J. Biol. Chem. 268(8) 5728-5734.
Lawton, M.P., Cashman J.R., Cresteil, T., Dolphin, C.T., Elfarra, A.A., Hines, R.N., Hodgson,
E., Kimura, T., Ozols, J., Phillips, I.R., Philpot, R.M., Poulsen, L.L., Rettie, A.E., Shephard,
E.A., Williams, D.E., Ziegler, D.M. 1994. A nomenclature for the mammalian flavin-containing
monooxygenase gene family based on amino acid sequence identities. Arch. Biochem. Biophys.
308, 254-257.

132

Lee, J.B., Sohn, H.Y., Shin, K.S., Jo, M.S., Jeon, C.P., Jang, J.O., Kim, J.E., Kwon, G.S., 2008.
Microbial biodegradation and toxicity of vinclozolin and its toxic metabolite 3,5-dichloroaniline.
J. Microbiol. Biotechnol. 18, 343-349.
Lee, J.H., Oh, C.S., Mun, G.H., Kim, J.H., Chung, Y.H., Hwang, T.I., Shin, D.H., Lee, W.J.,
2006. Immunohistochemical localization of sodium-dependent L-ascorbic acid transporter 1
protein in rat kidney. Histochem. 126, 491-494.
Liao, Y.P., Hung, D.Z., Yang, D.Y., 2002. Hemolytic anemia after methylene blue therapy for
aniline-induced methemoglobinemia. Vet. Hum. Toxicol. 44(1),19-21.
Limban, C., Marutescu, L., Chifiriuc, M.C., 2011. Synthesis, spectroscopic properties and
antipathogenic activity of new thiourea derivatives. Molecules. 16, 7593-7607.
Lindh, C.H., Littorin, M., Amilon, A., Jönsson, B.A., 2007. Analysis of 3,5-dichloroaniline as a
biomarker of vinclozolin and iprodione in human urine using liquid chromatography/triple
quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 21, 536–42.
Litterst, C.L., Mimnaugh, E.G., Reagan, R.L., Gram, T.E., 1975. Comparison of in vitro drug
metabolism by lung, liver, and kidney of several common laboratory species. Drug Metabolism
and Disposition 3(4), 259-265.
Lo, H.H., Yang, D.J., Lahoda, E.P., Rankin, G.O., 1985. Acute N-(3,4,5trichlorophenyl)succinimide-induced nephrotoxicity in Sprague-Dawley and Fischer 344 rats.
Pharmacologist 27(3), 227.
Lo, H.H., Brown, P.I., Rankin, G.O., 1990. Acute nephrotoxicity induced by isomeric
dichloroanilines in Fischer 344 rats. Toxicology 63, 215–31.
Lo, H.H., Brown, P.I., Rankin, G.O., 1991. Trichloroaniline effects on renal function in vivo
and in vitro. Toxicol. Lett. 58, 319-328.
Lo, H.H., Valentovic, M.A., Brown, P.I., Rankin, G.O., 1994. Effect of chemical form, route of
administration and vehicle on 3,5-dichloroaniline-induced nephrotoxicity in the Fischer 344 rat.
J Appl Toxicol 14, 417–22.
Lock, E.A., Cross, T.J., Schnellmann, R.G., 1993. Studies on the mechanism of 4-aminophenolinduced toxicity to renal proximal tubules. Hum Exp Toxicol 12, 383–8.
Loew, G.H., Goldblum, A., 1985. Metabolic activation and toxicity of acetaminophen and
related analogs: A theoretical study. Mol. Pharmcacol. 27, 375-386.
Lohr, J.W., Willsky, G.R., Acara, M.A., 1998. Renal drug metabolism. Pharmacol. Rev. 50, 107141.

133

Lyons, C.D., Katz, S.E., Bartha, R., 1984. Mechanisms and pathways of aniline elimination
from aquatic environments. Applied and Environmental Microbiology. 48, 491-496.
Lyons, C.D., Katz, S.E., Bartha, R., 1985. Persistence and mutagenic potential of herbicidederived aniline residues in pond water. Bulletin of Environmental Contamination and
Toxicology. 35, 696-703.
Ma, H., Wang, J., Abdel-Rahman, S.Z., Boor, P.J., Khan, M.F., 2008. Oxidative DNA damage
and its repair in rat spleen following subchronic exposure to aniline. Toxicol. Appl. Pharmacol.
233, 247–53.
Ma, H., Wang, J., Abdel-Rahman, S.Z., Boor, P.J., Khan, M.F., 2013. Induction of base excision
repair enzymes NTH1 and APE1 in rat spleen following aniline exposure. Toxicol. Appl.
Pharmacol. 267, 276–83.
Macherey, A-C., Dansette, P.M., 2008. Biotransformation leading to toxic metabolites: Chemical
aspects. Wemuth’s The Practice of Medicinal Chemistry. Elsevier Ltd. 674-696.
Machlin, L.J., Bendich, A., 1987. Free radical tissue damage: Protective role of antioxidant
nutrients. FASEB J. 1, 441-445.
Marbouh, L. El., Arellano, C., Philibert, C., Evrard, P., Poey, J., Houin, G., 2002. Development
and evaluation of an HPLC urinalysis screening test for occupational exposure to 3,4- and 3,5dichloroanilines. Int. J. Clin. Pharmacol. Ther. 40(1), 41-46.
Mazze, R.I., Cousins, M.J., Kosek, J.C., 1973. Strain differences in metabolism and
susceptibility to the nephrotoxic effects of methoxyflurane in rats. J. Pharmacol. Exp. Ther.
184(1), 481-488.
McLellan, R.A., Oscarson, M., Seidefard, J., Evans, D.A., Ingelman-Sundberg, M., 1997.
Pharmacogenetics 7(3), 187-191.
McMillan, D.C., Leakey, J.E., Arlotto, M.P., McMillan, J.M., Hinson, J.A., 1990. Metabolism of
the arylamide herbicide propanil. II. Effects of propanil and its derivatives on hepatic
microsomal drug-metabolizing enzymes in the rat. Toxicol. Appl. Pharmacol. 103, 102–12.
McMillan, D.C., Jensen, C.B., Jollow, D.J., 1998. Role of lipid peroxidation in Dapsone-induced
hemolytic anemia. J. Pharmacol. Exp. Ther. 287(3), 868-876.
McMurtry, R.J., Snodgrass, W.R., Mitchell, J.R., 1978. Renal necrosis, glutathione depletion,
and covalent binding after acetaminophen. Toxicol. Appl. Pharmacol. 46, 87-100.
Mercadier, C., Vega D., Bastide, J., 1998. Chemical and biological transformation of the
fungicide vinclozolin. J. Agric. Food Chem. 46, 3817-3822.

134

Michail, K., Baghdasarian, A., Narwaley, M., Aljuhani, N., Siraki, A.G., 2013. Scavenging of
free-radical metabolites of aniline xenobiotics and drugs by amino acid derivatives: toxicological
implications of radical-transfer reactions. Chem. Res. Toxicol. 26, 1872-1883.
Milne, G.W.A., 2005. Gardner’s commercially important chemicals. P 44.
Mulder, G.J., Jakoby, W.B., 1990. Sulfation, in Conjugation Reactions in Drug Metabolism. (ed.
Mulder G.J.). Taylor and Francis, London 107-162.
Muller, F., 1887. Dtsch. Med. Wschr. 13, 24.
Nagata, K., Yamazoe, Y., 2000. Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol.
Toxicol. 40, 159-176.
Nascimento, T.S., Pereira, R.O.L, de Mello, H.L.D, Costa, J., 2008. Methemoglobinemia: from
diagnosis to treatment. Rev. Bras. Anestesiol. 58(6), 651-664.
Nelson, D.R., Kamataki, T., Waxmand, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, R.,
Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., et al. 1993. The P450 superfamily: update
on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and
nomenclature. DNA Cell Biol. 12(1), 1-51.
Nelson, D.R., 2004. Cytochrome P450 nomenclature 2004. Methods Mol. Biol. 320, 1-10.
Newell, M., Argus, M., Ray, F.E., 1960. Routes of metabolism of [36Cl] ring-substituted
monochloroacetanilides. Biochem. Pharmacol. 5, 30-38.
Newton, J.F., Kuo, C.H., Gemborys, M.W., Mudge, G.H., Hook, J.B., 1982. Nephrotoxicity of paminophenol, a metabolite of acetaminophen, in the Fischer 344 rat. Toxicol. Appl. Pharmacol.
65, 336-344.
Nomura A., 1975. Formulation of sulfhemoglobin using various drugs. Nihon Yakurigaku
Zasshi. 71(4), 351-365.
O’Brien, P.J., Siraki, A.G., 2005. Accelerated cytotoxicity mechanism screening using drug
metabolising enzyme modulators. Curr. Drug Metab. 6, 101–9.
Ochiai, Y., Sakurai, E., Nomura, A., Itoh, K., Tanaka, Y., 2006. Metabolism of nicotine in rat
lung microvascular endothelial cells. J. Pharm. Pharmacol. 58, 403–7.
Ohkawa, H., Hisada, Y., Fujiwara, N., Miyamoto, J., 1974. Metabolism of N-(3’,5’dichlorophenyl)succinimide in Rats and Dogs. Agr. Biol. Chem. 38(7), 1359-1369.
Omura, T., Sato, R., 1964a. The carbon monoxide-binding pigment of liver microsomes. I.
Evidence for its hemoprotein nature. Journal of Biological Chemistry. 239, 2370-2378.

135

Omura, T., Sato, R., 1964b. The carbon monoxide-binding pigment of liver microsomes II.
Solubilization, purification, and properties. Journal of Biological Chemistry. 239, 2378-2385.
Parke, D.V., 1960. The metabolism of [14C]-aniline in the rabbit and other animals. Biochem. J.
77, 493.
Parkinson, A., 2001. Biotransformation of xenobiotics. In Klaassen, C.D. (Eds). Toxicology: the
basic science of poisons, 6th edition. (p 133-224). McGraw-Hill Medical Publishing Division.
Pauluhn, J. 2004. Subacute inhalation toxicity of aniline in rats: analysis of time-dependence and
concentration-dependence of hematotoxic and splenic effects. Toxicological Sciences 81, 198215.
Perkin, W.H., 1879. On mauveine and allied clouring matters. J. Chem. Soc. Trans. 717-732.
Peters, A.T., Yang., S.S.,1996. Monoazo disperse dyes derived from mononitro-dichloro-2aminobenzothiazoles. Dyes Pigments. 30, 291-299.
Phillips, I.R., Dolphin, C.T., Clair, P. Hadley, M.R., Hutt, A.J., McComie, R.R., Smith, R.L.,
Shephard, E.A., 1995. The molecular biology of the flavin-containing monooxygenases of man.
Chemico-Biol. Interactions 96, 17-32.
Pizon, A.F., Schwartz, A.R., Shum, L.M., Rittenberger, J.C., Lower, D.R., Giannoutsos, S., Virji,
M.A., Krasowski, M.D., 2009. Toxicology laboratory analysis and human exposure to pchloroaniline. Clin. Toxicol. (Phila). 47(2), 132-136.
Poli, G., Parola, M., 1996. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22, 287305.
Racine, C., Ward, D., Anestis, D., Ferguson, T., Preston, D., Rankin, G., 2014. 3,4,5Trichloroaniline Nephrotoxicity in Vitro: Potential Role of Free Radicals and Renal
Biotransformation. Int. J. Mol. Sci. 15, 20900-20912.
Racine, C.R., Ferguson, T., Preston, D., Ward, D., Ball, J., Anestis, D., Valentovic, M., Rankin,
G.O., 2016. The role of biotransformation and oxidative stress in 3,5-dichloroaniline (3,5-DCA)
induced nephrotoxicity in isolated renal cortical cells from male Fischer 344 rats. Toxicology.
341-343, 47-55.
Ramsey, D.H., Harvey, C.C., 1959. Markingink poisoning: an outbreak of methaemoblobin
cyanosis in newborn babies. Lancet. 1(7079), 910-012.
Rankin, G.O., Yang, D.J., Lahoda, E.P., Cressey-Veneziano, K., Bailey, M.L., Brown, P.I. 1985.
Acute nephrotoxicity of N-phenyl and N-(monochlorophenyl) succinimides in Fischer 344 and
Sprague-Dawley rats. Toxicology. 34(4), 299-308.

136

Rankin, G.O., Yang, D.J., Teets, V.J., Lo, H.H., Brown, P.I., 1986. 3,5-Dichloroaniline-induced
nephrotoxicity in the Sprague-Dawley rat. Toxicol. Lett. 30, 173–9.
Rankin, G.O., Yang, D.J., Cressey-Veneziano, K., Casto, S., Wang, R.T., Brown, P.I. 1986a. In
vivo and in vitro nephrotoxicity of aniline and its monochlorophenyl derivatives in the Fischer
344 rat. Toxicology. 38(3), 269-283.
Rankin, G.O., Valentovic, M.A., Beers, K.W., Nicoll, D.W., Ball, J.G., Anestis, D.K., Brown,
P.I., Hubbard, J.L., 1993. Renal and hepatic toxicity of monochloroacetanilides in the Fischer
344 rat. Toxicology 79, 181–93.
Rankin, G.O., Valentovic, M.A., Nicoll, D.W., Ball, J.G., Anestis, D.K., Wang, R.T., Brown,
P.I., 1994. In vivo and in vitro 4-amino-2,6-dichlorophenol nephrotoxicity and hepatotoxicity in
the Fischer 344 rat. Toxicology 90, 115–28.
Rankin, G.O., Valentovic, M.A., Hong S.K., Anestis, D.K., Ball, J.G., Dial, L.D., 1995. In vitro
and acute in vivo renal effects induced by 2-chloro-4-hydroxyacetanilide and 4-chloro-2hydroxyacetanalide in the Fischer 344 rat. Toxic Substances Mechanisms 14, 93-109.
Rankin, G.O., Beers, K.W., Nicoll, D.W., Anestis, D.K., Hong, S.K., Hubbard, J.L., Ball, J.G.,
Valentovic, M.A., Brown, P.I., 1996. Nephrotoxic potential of 2-amino-5-chlorophenol and 4amino-3-chlorophenol in Fischer 344 rats: comparisons with 2- and 4-chloroaniline and 2- and 4aminophenol. Toxicology 108, 109–23.
Rankin, G.O., Hong, S.-K.K., Anestis, D.K., Ball, J.G., Valentovic, M.A., 2008a. Mechanistic
aspects of 4-amino-2,6-dichlorophenol-induced in vitro nephrotoxicity. Toxicology 245, 123–9.
Rankin, G.O., Racine, C., Sweeney, A., Kraynie, A., Anestis, D.K., Barnett, J.B., 2008b. In vitro
nephrotoxicity induced by propanil. Environ. Toxicol. 23, 435–42.
Rickert, D.E., Held, S.D., 1990. Metabolism of chloronitrobenzenes by isolated rat hepatocytes.
Drug Metab. Dispos. 18, 5-9.
Rodriguez, R.J., Acosta, D., 1997. N-deacetyl ketoconazole-induced hepatotoxicity in a primary
culture system of rat hepatocytes. Toxicology 117, 123–31.
Rondestvedt, C.S., Johnson, T.A., 1977. Synthesis, 851.
Rooseboom, M., Commandeur, J.N.M., Floor, G.C., Rettie, A.E., Vermeulen, N.P.E., 2001.
Selenoxidation by flavin-containing monooxygenase as a novel pathway for β-elimination of
selenocysteine Se-conjugates. Chem. Res. Toxicol. 14(1), 127-134.
Rose, F.L., Swain, G., 1956. 850. Bisdiguanides having antibacterial activity. J. Chem. Soc.
4422-4425.
Rossoff, I.S., 2002. Encylopedia of clinical toxicology. P 718.

137

Sanchez, IR., Swaim, S.F., Nusbaum, K.E., Hale, A.S., Henderson, R.A., McGuire, J.A., 1988.
Effects of chlorhexidine diacetate and providone-iodine on wound healing in dogs. Veterinary
Surgery 17, 291-295.
Santos, T.C.R., Rocha, J.C., Alonso, R.M., Martinez, E., Ilbanzez, C., Barcelo, D., 1998. Rapid
degradation of propanil in rice field crops. Environ. Sci. Technol. 32, 3479-3484.
Schlichting, I., Berendzen, J., Chu, K., Stock, A.M., Maves, S.A., Benson, D.E., Sweet, R.M.,
Ringe, D., Petsko, G.A., Sligar, S.G., 200. The catalytic pathway of cytochrome p450cam at
atomic resolution. Science 287(5458), 1615-1622.
Schmiedeberg, O. 1878. Arch. Exp. Path. Pharmak. 8, 1.
Scotti, P., Tomasini, M., 1966. On a case of grave acute poisoning by parachloroaniline with
intense methemoglobinemia and transitory electrocardiographic changes. Med. Lav. 57(11), 662666.
Searle, N.C., Cupery, H.E., 1954. Synthesis of carbon-14 labeled 3-(p-chlorophenyl)-1,1dimethylurea. J. Org. Chem. 19, 1622-1627.
Smith, J.N., Williams, R.T., 1949. The fate of aniline in the rabbit. Biochem. J. 44, 242.
Spatzenegger, M., Born, S.L., Halpert, J.R., 2003. Cytochrome P450 in laboratory animal
species. In Lee, J.S., Obach, R.S., Fisher, M.B. (eds). Drug metabolizing enzymes: cytochrome
p450 and other enzymes in drug discovery and development. CRC Press
Stadtman, E.R., Oliver, C.N., 1991. Metal-catalyzed oxidation of proteins. Physiological
consequences. J. Biol. Chem. 266(4), 2005-2008.
Stiborová, M., Frei, E., Schmeiser, H.H., Wiessler, M., Anzenbacher, P., 1992. Peroxidase
oxidizes N-nitrosomethylaniline to ultimate carcinogens(s) binding to DNA and transfer RNA in
vitro. Cancer Lett. 63, 53–9.
Sun, H., Ehlhardt, W.J., Kulanthaivel, P., Lanza, D.L., Reilly, C.A., Yost, G.S., 2007.
Dehydrogenation of indoline by cytochrome P450 enzymes: a novel “aromatase” process. J.
Pharmacol. Exp. Ther. 322, 843–51.
Suzuki, Y., Sudo, J., 1990. Lipid peroxidation and generations of oxygen radicals induced by
cephaloridine in renal cortical microsomes of rats. Jpn. J. Pharmacol. 52, 233–43.
Tarloff, J.B., Goldstein, R.S., Morgan, D.G., Hook, J.B., 1989. Acetaminophen and paminophenol nephrotoxicity in aging male Sprague-Dawley and Fischer 344 rats. Fundamental
and applied toxicology: official journal of the Society of Toxicology 12, 78–91.

138

Terneus, M.V., Kiningham , K.K., Carpenter, A.B., Sullivan, S.B., Valentovic, M.A., 2007.
Comparison of S-Adenosyl-L-methionine and N-acetylcysteine protective effects on
acetaminophen hepatic toxicity. J. Pharmacol. Exp. Ther. 320, 99–107.
Tukey, R.H., Strassburg, C.P., 2000. Human UDP-glucuronosyltransferases: metabolism,
expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40, 581-616.
Turci, R., Barisano, A., Baldducci, C., Colosio, C., Minoia, C., 2006. Determintation of
dichloroanilines in human urine by gas chromatography/mass spectrometry: Validation protocol
and establishment of reference values in a population group living in central Italy. Rapid
Commun. Mass Spectrom. 20, 2621-2625.
Tynes, R.E., Sabourin, P.J., Hodgson, E., Philpot, R.M., 1986. Formation of hydrogen peroxide
and N-hydroxylated amines catalyzed by pulmonary flavin-containing monooxygenase in the
presence of primary alkylamins. Arch. Biochem. Biophys. 251, 654-664.
Udeh, C., Bittikofer, J., Sum-Ping, S.T.J., 2001. Severe methemoglobinemia on reexposure to
benzocaine. J. Clin. Anesth. 13, 128-130.
Umbreit, J., 2007. Methemoglobin--it’s not just blue: a concise review. Am. J. Hematol. 82, 134–
44.
Unger, T.A., 1996. Pesticide synthesis handbook. Noyses Publications, New Jersey. pp.
449,487,494.
Valentovic, M.A., Ball, J.G., Anestis, D.K., Beers, K.W., Madan, E., Hubbard, J.L., Rankin,
G.O., 1992. Acute renal and hepatic toxicity of 2-haloanilines in Fischer 344 rats. Toxicology 75,
121–31.
Valentovic, M.A., Ball, J.G., Anestis, D.K., Rankin, G.O., 1995a. Comparison of the in vitro
toxicity of dichloroaniline structural isomers. Toxicol In Vitro 9, 75–81.
Valentovic, M.A., Lo, H.H., Brown, P.I., Rankin, G.O., 1995b. 3,5-Dichloroaniline toxicity in
Fischer 344 rats pretreated with inhibitors and inducers of cytochrome P450. Toxicol. Lett. 78,
207–14.
Valentovic, M.A., Ball J.G., Hong, S.K., Rogers, B.A., Meadows, M.K., Harmon, R.C., Rankin,
G.O., 1996. In vitro toxicity of 2- and 4-chloroaniline: Comparisons with 4-amino-3chlorophenol, 2-amino-5-chlorophenol and aminophenols. Toxicol In Vitro 10, 713-720.
Valentovic, M.A., Rogers, B.A., Meadows, M.K., Conner, J.T., Williams, E., Hong, S.K.,
Rankin, G.O., 1997. Characterization of methemoglobin formation induced by 3,5dichloroaniline, 4-amino-2,6-dichlorophenol and 3,5-dichlorophenylhydroxylamine. Toxicology
118, 23–36.

139

Valentovic, M., Meadows, M.K., Harmon, R.C., Ball, J.G., Hong, S.K., Rankin, G.O., 1999. 2Amino-5-chlorophenol toxicity in renal cortical slices from Fischer 344 rats: effect of
antioxidants and sulfhydryl agents. Toxicol. Appl. Pharmacol. 161, 1–9.
Valentovic, M., Ball, J.G., Stoll, S., Rankin, G.O., 2001. 3,4-Dichlorophenylhydroxylamine
cytotoxicity in renal cortical slices from Fischer 344 rats. Toxicology 162, 149–56.
Valentovic, M.A., Ball, J.G., Sun, H., Rankin, G.O., 2002. Characterization of 2-amino-4,5dichlorophenol (2A45DCP) in vitro toxicity in renal cortical slices from male Fischer 344 rats.
Toxicology 172, 113-123.
Valentovic, M., Terneus, M., Harmon, C.R., Carpenter, B.A., 2004. S-Adenosylmethionine
(SAMe) attenuates acetaminophen hepatotoxicity in C57BL/6 mice. Toxicology letters 154, 165–
174.
Van Berkel, W.J.H., Namerbeek, N.M., Fraaije, M.W., 2006. Flavoprotein monooxygenases, a
diverse class of oxidative biocatalysts. Journal of Biotechnology. 124, 670-689.
Vangnai, A.S., Kataoka, N., Soonglerdsongpha, S., Kalambaheti, C., Tajima, T., Kato, J., 2012.
Construction and application of an Escherichia coli bioreporter for aniline and chloroaniline
detection. J. Ind. Microbiol. Biotechnol. 39, 1801-1810.
Vitelli, N., Chiodini, A., Colosio, C., de Paschale, G., Somaruga, C., Turci, R., Minoia, C.,
Brambilla, G., Colombi, A., 2007. Occupational and environmental exposure to anilide and
dicarboximide pesticides. G. Ital. Med. Lav. Ergon. 29, 276-277.
Walker, A. 1987a. Further observations on the enhanced degradation of iprodione and
vinclozolin in soil. Pestic. Sci. 21, 219-231.
Walker, A., 1987b. Enhanced degradation of iprodione and vinclozolin in soil: a simple
colorimetric test for identification of rapid-degrading soils. Pestic. Sci. 21, 233-240.
Ward, J.M., Reznik, G., Garner, F.M., 1980. Proliferative lesions of the spleen in male F344 rats
fed diets containing p-chloroaniline. Vet. Pathol. 17, 200-205.
Warren, S., Wyatt, P., 2008. Organic synthesis: the disconnection approach (2nd ed.). Oxford:
Wiley-Blackwell. p. 25.
Waterman M.R., Johnson E.F. (eds), 1991. Cytochrome P450. Methods in Enzymology. Vol 206.
Academic Press: New York
Wegman, R.C., de Korte, G.A.L., 1981. Aromatic amines in surface waters of the Netherlands.
Water Research 15, 359-360.

140

Weinberger, M.A., Albert, R.H., Montgomery, S.B., 1985. Splenotoxicity associated with
splenic sarcomas in rats fed high doses of D & C Red No. 9 or aniline hydrochloride. J. Natl.
Cancer Inst. 75(4), 681-690.
Whitcomb, D.C., Block, G.D., 1994. Association of acetaminophen hepatatoxicity with fasting
and ethanol use. JAMA 272, 1845-1850.
Williams, R. 1959. Detoxication Mechanisms, 2nd Edition. John Wiley & Sons: New York, p.
796.
Yanni, S.B., Annaert, P.P., Augustijns, P., Ibrahim, J.G., Benjamin, D.K., Thakker, D.R., 2010.
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults:
role of CYP2C19 and flavin-containing monooxygenase 3. Drug Metab. Dispos. 38, 25–31.
Yang, D.J., Lahoda, E.P., Brown, P.I., Rankin, G.O. 1985a. Acute nephrotoxicity of isomeric N(dichlorophenyl)succinimides in Sprague-Dawley and Fischer 344 rats. Toxicol. Sci. 5, 11191127.
Yang, D.J., Lahoda, E.P., Brown, P.I., Rankin, G.O. 1985. Structure-nephrotoxicity relationships
for para-substituted N-phenylsuccinimides in Sprague-Dawley and Fischer 344 rats. Toxicology.
36(1), 23-25.
You, I.S., Bartha, R., 1982. Metabolism of 3,4-dichloroaniline by Pseudomonas putida. J. Agric.
Food Chem. 30(2), 274-277.
Zanger, U.M., Turpeinen, M., Klein, K., Schwab, M. 2008. Functional
pharmacogenetics/genomics of human cytochrome P450 involved in drug biotransformation.
Anal. Bioanal. Chem. 392, 1093-1108.
Zeigler, D.M., 1980. Microsomal flavin-containing monooxygenase: oxygenation of nucleophile
nitrogen and sulfur compounds. Enzymatic. Basis Detox. 1, 201-217.
Zober, A., Hoffman, G., Ott, M.G., Will, W., Germann, C., van Ravenzwaay, B., 1995. Study of
morbidity of personnel with potential exposure to vinclozolin. Occup Environ Med 52, 233-241.

141

APPENDIX A: INSTITUTIONAL REVIEW BOARD APPROVAL
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APPENDIX B: LIST OF ABBREVIATIONS
2A46DCP…2-amino-4,6-dichlorophenol
2-BrA…2-bromoaniline
2-CA…2-chloroaniline
2-FA…2-fluoroaniline
2-IA…2-iodoaniline
3,5-DCA…3,5-dichloroaniline
3,5-DCAA…3,5-dichloroaceataniline
3,5-DCNB…3,5-dichloronitrobenzene
3,5-DCNSB…3,5-dichloronitrosobenzene
3,5-DCPHA…3,5-dichlorophenylhydroxylamine
4A26DCP…4-amino-2,6-dichlorophenol
4-CA…4-chloroaniline
α-Toc… α-tocopherol
AAALAC…Association for the Assessment and Accreditation of Laboratory Animal Care
International
AALAS…American Association of Laboratory Animal Sciences
ADCP…4-amino-2,6-dichlorophenol
ALT/GPT…alanine aminotransferase
ASC…ascorbate
BUN…blood urea nitrogen
CYP…cytochrome P450
DCA…dichloroaniline
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DEDTCA…diethyldithiocarbamate
DMSO…dimethyl sulfoxide
DNP…2,4-dinitrophenylhydrazone
GPT…glutamic-pyruvic transaminase
GSH…gluthathione
GSSG…oxidized glutathione
FAD/FADH2…flavin adenine dinucleotide
FMO…FAD-containing monooxygenase, Flavin-containing monooxygenase
HPLC…high pressure liquid chromatography
i.p….intraperitoneal
IRCC…isolated renal cortical cells
KH…Krebs Heinselt
LDH…lactate dehydrogenase
MeOH…methanol
NAC…N-acetyl-L-cysteine
NAD/NADH…nicotinamide adenine dinucleotide
NAPQI…N-acetyl-p-benzoquinone
NAT…N-acetyltranferase
NDPS…N-(3,5-dichlorophenyl)-succinimide
PAH…p-aminohippurate
PAPS…3’-phosphoadenosine-5’-phosphosulfate
PHS…prostaglandin H synthase
PiBX…piperonyl butoxide
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SMP…submitochondrial particles
TCA…3,4,5-trichloroaniline
TEA…tetraethylammonium
UDP…uridine disphosphate
UGT…UDP-glucuronosyl tranferase
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